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ABSTRACT 
Proteogenomics is an area of proteomics concerning the detection of novel peptides and peptide 
variants nominated by genomics and transcriptomics experiments. While the term primarily 
refers to studies utilizing a customized protein database derived from select sequencing 
experiments, proteogenomics methods can also be applied in the quest for identifying previously 
unobserved, or missing, proteins in a reference protein database. The identification of novel 
peptides is difficult and results can be dominated by false positives if conventional 
computational and statistical approaches for shotgun proteomics are directly applied without 
consideration of the challenges involved in proteogenomics analyses. In this dissertation, I 
systematically distill the sources of false positives in peptide identification and present potential 
remedies, including computational strategies that are necessary to make these approaches 
feasible for large datasets. 
 
In the first part, I analyze high scoring decoys, which are false identifications with high assigned 
confidences, using multiple peptide identification strategies to understand how they are 
generated and develop strategies for reducing false positives. I also demonstrate that modified 
peptides can cause violations in the target-decoy assumptions, which is a cornerstone for error 
rate estimation in shotgun proteomics, leading to potential underestimation in the number of false 
positives. Second, I address computational bottlenecks in proteogenomics workflows through the 
development of two database search engines: EGADS and MSFragger. EGADS aims to address 
issues relating to the large sequence space involved in proteogenomics studies by using graphical 
processing units to accelerate both in-silico digestion and similarity scoring. MSFragger 
implements a novel fragment ion index and searching algorithm that vastly speeds up spectra 
similarity calculations. For the identification of modified peptides using the open search strategy, 
MSFragger is over 150X faster than conventional database search tools. Finally, I will discuss 
refinements to the open search strategy for detecting modified peptides and tools for improved 
collation and annotation. Using the speed afforded by MSFragger, I perform open searching on 
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several large-scale proteomics experiments, identifying modified peptides on an unprecedented 
scale and demonstrating its utility in diverse proteomics applications. 
 
The ability to rapidly and comprehensively identify modified peptides allows for the reduction of 
false positives in proteogenomics. It also has implications in discovery proteomics by allowing 
for the detection of both common and rare (including novel) biological modifications that are 
often not considered in large scale proteomics experiments. The ability to account for all 
chemically modified peptides may also improve protein abundance estimates in quantitative 
proteomics.
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CHAPTER I 
INTRODUCTION TO SHOTGUN PROTEOMICS AND 
PROTEOGENOMICS 
1.1 Venturing beyond the reference proteome 
In May 2014, more than thirteen years after the draft of the human genome [1,2], two studies 
from independent groups appeared in Nature each claiming to have completed the first draft of 
the human proteome [3,4]. These drafts of the human proteome were based on mass 
spectrometry-based proteomics, the now dominant tool for large-scale proteome analysis. In 
these studies, data was generated from diverse human tissues, or otherwise aggregated from 
public repositories, to build a comprehensive catalog of human proteins. From the roughly 
20,000 protein-coding genes, both studies reported mass-spectrometry evidence for over 17,000 
protein-coding genes.  Immediately after these heavily publicized publications, much criticism 
was raised in the proteomics community regarding the lax false discovery rate (FDR) filtering 
used in the studies. Several re-analyses of these datasets only identified 13-14,000 proteins [5] 
and others raised concerns about the large number of olfactory receptor proteins identified in 
non-nasal tissues (allegedly due to poor quality spectra and non-unique peptides) [6]. As a result, 
guidelines were established for calling novel (as was the case for many peptides and proteins in 
these studies) identifications [7] and subsequent work from one of the groups publishing the draft 
proteome have revised downwards their observed number of proteins to less than 15,000 [8], 
more than 2,000 fewer than what was originally claimed. The drafts of the human proteome and 
the subsequent controversy illustrate the numerous statistical pitfalls and computational 
challenges surrounding mass spectrometry-based proteomics. 
 
The concept of novel identifications in attempts to define the proteome can be a bit misleading as 
modern high-throughput proteomics studies relies on databases of protein sequences derived 
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from genomics and transcriptomics studies. Hence, defining the proteome is more of an exercise 
in validating predicted protein products rather than directly observing proteins and their 
sequences. This is in contrast to the efforts in the early 1990s, prior to the availability of genomic 
or protein databases, where Edman sequencing of intact proteins or enzymatically-digested 
fragments was used to generate partial protein sequences for which degenerate oligonucleotide 
primers could be made to PCR the gene for sequencing [9]. Presently, the majority of proteomics 
studies utilize high quality reference databases generated from a combination of manual and 
automated curation such as UniprotKB [10] and Ensembl [11]. Others use custom protein 
databases [12] derived from related sequencing experiments to capture variants (both point and 
splice) [13] and non-canonical regions of coding potential (such as lncRNAs [14]). Studies of the 
latter type have been classified under the label of proteogenomics [7] in recent years as an 
emerging field of proteomics (Figure 1-1). Despite this classification, the methods and 
challenges involved in identifying novel peptides and proteins, whether they stem from entries in 
the reference database that have not been previously observed by mass spectrometry [5,15] or 
from predictions from sequencing data, are largely the same (rather unsurprising as the reference 
protein database is also derived from sequencing efforts). These efforts to characterizing the 
novel and unknown may also extend to the vast repertoire of post-translational modifications 
(PTMs) that regulate most proteins [16]. Together, they embody the frontiers of the observable 
proteome. In this dissertation, we define some of the challenges in these explorations beyond the 
reference proteome and present computational tools and strategies that address these issues. 
 
 
 
Figure 1-1 Proteogenomics workflow.  
Genomics and transcriptomics data are used to generate customized protein databases that are used for peptide identification. The 
identified peptides are then used to validate or refine gene models. 
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1.2 Mass spectrometry-based proteomics 
Modern high-throughput shotgun proteomics has its origins in the development of four crucial 
technologies in the 1980s and early 1990s. The first are the advances in peptide and protein 
ionization technologies such as MALDI (matrix-assisted laser desorption/ionization) and 
electrospray ionization that enabled the analysis of these biomolecules in mass spectrometers 
[17].  In particular, electrospray ionization is compatible with high performance liquid 
chromatography (HPLC) systems that are critical for separating peptides in complex biological 
mixtures. Second, the development of tandem (MS/MS) mass spectrometry enabled the rapid 
sequencing of peptides bypassing lengthy Edman sequencing [18]. In tandem mass spectrometry, 
peptide ions are collided or otherwise fragmented into peptide fragments and the mass spectra of 
the resultant fragments are collected. The peptides fragment primarily at the amide bonds 
between residues, allowing the sequence to be deduced by comparing the mass differences 
between series of ions to the mass of amino acids. The third are automated instrument control 
methods that enable mass spectrometers to dynamically select which ions to fragment based on 
the ions it observes eluting from chromatographic system in real time [19]. These data-dependent 
acquisition methods enable mass spectrometers to focus on the ions most likely to yield 
additional information about the sample (e.g. high intensity ions that have not already been 
fragmented, ions that do not correspond to signals of known chemical noise) as the number of 
eluting ions is far greater than the rate at which mass spectrometers can acquire tandem mass 
spectra.  Finally, and of particular focus in this dissertation, computational tools that can interpret 
and assign a peptide identification to these tandem mass spectra. Without these automated tools, 
the labor involved in manual interpretation would prohibit mass spectrometry-based proteomics 
from evolving into a high-throughput technology. 
 
In practice, the modern realizations of these technologies in shotgun proteomics are as follows 
[20]. Proteins are enzymatically digested, commonly with trypsin, into peptides that are loaded 
into an HPLC system coupled to a mass spectrometer. To reduce sample complexity (allowing 
lower abundance ions to be sampled in the mass spectrometer – resulting in greater proteome 
coverage), proteins and/or peptides can be fractionated in gels or another liquid chromatography 
system prior to loading. As peptides are eluted from the HPLC system, they are ionized and the 
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mass spectrometer generates a mass spectrum containing all eluting peptide ions (known as a 
survey or MS1 scan). Based on the acquired survey scan, the onboard computer selects a number 
of peptide ions to select for fragmentation (often the most abundant peptide ions). The mass 
spectrometer then iteratively applies a mass filter to the incoming stream of ions, selecting a 
narrow mass window around the selected peptide ion, and fragments the peptide ion into 
fragments. The fragment ions are then detected and recorded as a tandem (also called MS/MS, 
MS2, or fragmentation) spectrum. After a number of tandem mass spectra have been acquired, 
the selected masses are placed on an dynamic exclusion list [21] to avoid collecting additional 
mass spectra of the same peptide ion and a fresh survey scan is collected to select the next targets 
for fragmentation. The collected mass spectra can then be used for peptide identification and 
quantitation. 
 
While this model of data dependent acquisition has served as the primary workhorse of shotgun 
proteomics for nearly two decades, advances in instrument speed and accuracy in recent years 
have led to dramatic increases in the depth of proteome coverage and rate of acquisition. 
Detection of over 10,000 proteins is now routine for fractionated human cell line data [22,23] 
while single shot analysis of the yeast proteome (approximately 4000 proteins) can now be 
performed in an hour [24], in contrast to the 144 hours of analysis time required for experiments 
performed as recently as 2008 [25]. As a result of the ever-increasing instrument speed, the 
amount of experimental data generated has increased significantly. This is readily observed 
through the growth in the amount of data stored in public repositories of proteomics experiments 
(Figure 1-2).  
 
Much of this growth appears to be stimulated by the introduction of instruments that are able to 
acquire tens of high-resolution (tens of parts per million or less) tandem mass spectra per second 
such as the TripleTOF 5600 [26] or the Q Exactive [27] mass spectrometers. A deeper inspection 
of the PRIDE repository [28]  (Table 1-1) reveals that the majority of deposited data is indeed 
generated from these and related instruments. 
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Figure 1-2 Size of the PRIDE data repository of proteomics data over time as of March 2017.  
Project sizes are determined from the contents of their FTP directories. Project publication dates are used rather than submission 
dates. Popular mass spectrometers are plotted near their approximate release dates. 
  
Table 1-1 Top mass spectrometers in PRIDE as of March 2017. 
Instruments are extracted from PRIDE project pages with sizes determined from projects’ FTP directories. Projects analyzed 
using multiple instrument types are associated with all instruments, leading to some duplicate counting. 
Instrument Projects Total Size (TB) Year of Introduction 
Q Exactive 740 72.52 2011 [27] 
LTQ Orbitrap Velos 770 51.07 2009 [29] 
LTQ Orbitrap* 600 28.49 2005 [30] 
LTQ Orbitrap Elite 270 16.61 2012 [31] 
TripleTOF 5600 191 10.08 2011 [26] 
 
*In many projects, the annotations on the PRIDE project pages are incorrect, with experiments performed on LTQ Orbitrap Elite 
and LTQ Orbitrap Velos incorrectly labeled as LTQ Orbitrap. 
1.3 Methods for peptide identification in shotgun proteomics 
The automated interpretation of tandem mass spectra is an important part of any shotgun 
proteomics workflow. Peptide identification algorithms are assessed on both their ability to 
correctly identify peptides as well as their computational runtime as peptide identification is 
often a computational bottleneck in many proteomics workflows [20]. These runtime concerns 
may be more relevant than ever due to the volume of data generated by modern high-speed 
instruments. As previously described, peptide ions are typically fragmented at the amide bonds 
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between residues in tandem mass spectrometry.  However, the fragmentation does not occur 
uniformly [32] and the fragmentation spectrum often fail to contain a complete ion ladder for 
easy interpretation. Hence, there are multiple strategies for interpreting tandem mass spectra. 
 
There are three main classes of tools for peptide identification: database searching, tag-based 
searching, and de novo sequencing. The lines between the classes are often blurred as ideas 
between the classes can be combined to form hybrid strategies. One of the earliest tools to gain 
widespread adaptation was the database search tool SEQUEST [33] (also re-implemented as the 
open-source tool Comet [34]), which interpreted experimental spectrum by computing a cross 
correlation function against theoretical spectra derived from in-silico digested peptides in a 
protein database. This database search model has been adapted by numerous other tools 
including Mascot [35], X! Tandem [36], Andromeda [37], MS-GF+ [38] and countless others – 
varying in how they score or compare the experimental spectrum against theoretical spectra, or 
how the search space is partitioned and prioritized. Due to their performance in both accuracy 
and speed, they remain the dominant class of tools for peptide identifications. As more and more 
fragmentation spectra are collected and assembled in public repositories, the use of spectral 
libraries for peptide identifications have also emerged, despite initial comments that there are 
simply too many peptides to build an effective spectral library [33]. In spectral library searching, 
previously observed and identified fragmentation spectra are assembled [39] and compared 
against experimental spectra. The known fragmentation patterns (intensities of fragment ions) 
can be more discriminatory than the theoretical spectra predicted by database search tools but the 
approach is limited only to the previously identified peptides present in the spectral library. 
 
While the complete ion ladder is often missing from fragmentation spectra, there is often a 
partial ladder that reveals a subsequence of the peptide. Tag-based approaches use this 
information by looking for a partial ladder and using the derived information to filter a sequence 
database [40]. Compared to database searching, the tag-filtered list of candidates is much smaller 
so more computational intensive operations, such as the identification of unknown modifications 
[41], can be performed. De novo sequencing tools attempt to identify peptides from 
fragmentation spectra without the use of a reference database [42,43]. The main benefit of de 
novo sequencing tools is that they allow for the identification of peptides that are not known or 
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present in the reference database. They can also be used to identify post-translational 
modifications [44]. However, they are computationally expensive to use and require high-quality 
spectra, making them impractical in most high-throughput experiments. Hybrid de novo 
sequencing methods have been developed to use information from a reference database [45] or 
fragmentation information from spectral libraries [46]. 
 
Regardless of the approach used to identify peptides in a fragmentation spectrum, the output of 
each tool is the identified peptide, a raw score representing the quality or confidence of the 
assignment based on the tool’s internal scoring mechanism, and a calibrated score (such as a 
probability or expectation value) that normalizes the raw score (as it can be heavily dependent on 
peptide length or spectrum complexity) allowing for quality comparisons between different 
peptide to spectrum matches (PSMs). However, the quality and accuracy of these calibrated 
scores is much debated [47]. 
1.4 Error rate estimation in shotgun proteomics 
While peptide identification tools provide scores that estimates the quality of the peptide 
spectrum match, they do not provide any estimates on the number of false identifications in a 
given experiment. This problem is complicated by the fact that scores are not comparable 
between different identification tools and that the quality assessments of individual PSMs do not 
have access to information that can be derived from experiment-wide observations, such as the 
frequency of missed cleavages or instrument mass accuracy and calibration. Hence, peptide 
validation methods were developed that combines peptide identification scores with auxiliary 
information in a statistical framework that can estimate the number of correct and incorrect hits. 
One of the pioneering tools for peptide validation is PeptideProphet [48] which computed a 
discriminant score for each PSM and used the expectation-maximization algorithm to model the 
distributions of correct and incorrect hits. The models can then be used to estimate the 
probability of correct hits and establish thresholds for controlling error rates in an experiment. 
These principles also have been extended to proteins to control for error rates at the protein level 
[49].  
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Complementary to these modeling based methods, the use of decoy sequences is widespread in 
shotgun proteomics [50]. Decoy sequences are peptide or protein sequences that are artificial and 
should not be found in nature. Hence, by searching against decoy sequences, it is possible to 
estimate the rate of error matches or the distribution of random scores. Decoy sequences were 
first generated from reversed protein sequences [51] but reversed peptides have been shown to 
perform similarly and may be superior for high mass accuracy data as they preserve the 
distribution of  peptide masses. Decoys have also been incorporated into peptide and protein 
validation models as negative examples in semi-supervised modeling [52,53]. In addition to 
serving as negative examples in statistical modeling, they can also be used to directly and 
empirically estimate the false discovery rate in a given experiment. In a common target-decoy 
approach, a combined database is generated with targets (the protein database of interest) and 
decoys of equal length (from reversed proteins or peptides). Experimental fragmentation spectra 
are then searched against this combined database using a peptide identification tool. Under the 
target-decoy assumption that incorrect assignments will match equally to target and decoy 
sequences, the number of false positives is equal to the number of decoy matches so the false 
discovery rate can be estimated by dividing the number of decoy hits to the number of target hits. 
A scoring threshold can then be set to achieve a target false discovery rate. Not only does the 
target-decoy approach allow estimation of false discovery rates at the PSM level, it can also be 
used to estimate FDR at the peptide or protein level. 
Error rate estimation in shotgun proteomics remains an area of active development. This is 
especially true for error rate estimation in very large datasets [8,54,55] and the use of different 
prior probabilities by integrating abundance information from transcriptomics or proteomics 
repositories [55,56], both of which are relevant in a proteogenomics context. 
1.5 False positives in proteogenomics analyses 
While false positives are produced as part of any shotgun proteomics analysis workflow, there 
are two key considerations that are of particular importance for proteogenomics: class-specific 
FDR estimation and false identifications of nonrandom nature [7]. In conventional proteomics 
analyses, a score threshold is selected to achieve a particular FDR for the entire dataset, typically 
using the target-decoy approach. This approach has proved problematic for proteogenomics 
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analyses as the likelihoods for identifying novel peptides are different than for abundant peptides 
and much stronger evidence is needed to support a novel identification. Failure to account for 
these differences have cause dramatic underestimation of the FDR for novel peptides [57]. In one 
proteogenomics study examining aberrant peptides in cancer, a global 1% FDR filter resulted in 
a 36% FDR amongst the novel peptide identifications [58]. Performing FDR estimation 
separately for known peptides and novel peptides allowed a 1% FDR to be achieved in both 
classes.  A theoretical analysis of this problem has demonstrated that a more complete annotation 
of the genome is linked to the degree of FDR underestimation for novel peptides (when a global 
FDR filter is used) [59]. While there are proteogenomics studies that employ class specific FDR 
estimation [60], the vast majority do not [3,4,13], leading to over-reporting of novel discoveries. 
The second major challenge facing proteogenomics analyses is the high degree of similarity 
between certain novel candidates and previously identified peptides in the reference database. 
Many novel peptides in proteogenomics originate from non-synonymous single nucleotide 
polymorphisms in the sequencing data. As these single amino acid substitutions can be similar or 
identical in mass with common chemical modifications, spectra of modified peptides can be 
misidentified as a novel variant peptide [61]. For example, the change in mass for an alanine to 
serine substitution or a phenylalanine to tyrosine substitution is identical to that of oxidation, an 
abundant chemical modification. As these incorrect assignments are due to chemically modified 
peptides, their fragmentation patterns are of a non-random nature and these errors may not be 
well modeled by the target-decoy strategy. While a number of such errors have been manually 
curated from the human draft proteome studies [5], there is a need to systematically annotate and 
study such errors. 
1.6 Outline 
False positives present two major challenges for proteogenomics analyses. The first concerns the 
sensitivity of proteogenomics experiments. Discovery of novel peptides involves the testing of 
large hypothesis spaces generated from sequencing experiments, requiring much stronger 
evidence for the identification of novel peptides when class specific FDR estimation is applied. 
When there is an abundance of false positives, the sensitivity of the experiment can be greatly 
affected making it impossible to detect any novel peptide at a reasonable FDR. The second 
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involves chemically or biologically modified peptides that might be misidentified as a novel 
variant peptide. It is unclear whether these false positives are correctly modeled by the target-
decoy approach as spectra from modified peptides can resemble spectra of novel variant peptides 
or other peptides in the reference database and may not match with equal propensity to target and 
decoy sequences. Even if these misidentifications are effectively captured by the target-decoy 
strategy, their presence as false positives in proteogenomics analyses might also decrease 
sensitivity. 
 
The overall aim of this dissertation is to develop computational strategies that address these 
concerns in proteogenomics analyses. In Chapter Two, I examine the causes and composition of 
false positives in shotgun proteomics while exploring the effects of modified peptides in false 
discovery rate estimation using multiple peptide identification tools. In Chapter Three, I develop 
two database search tools that reduce the computation time required in proteogenomics analyses, 
enabling more comprehensive peptide identifications that can reduce false positives. In Chapter 
Four, I refine the open search strategy for identifying modified peptides and apply it to large 
scale proteomics experiments for profiling modified peptides in a number of proteomics 
experiments and applications. 
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CHAPTER II 
CHARACTERIZATION AND REMEDIATION OF FALSE 
POSITIVES IN PROTEOGENOMICS WORKFLOWS 
Portions of this chapter comparing narrow window and open search results have been published 
in Nature Methods [62] 
2.1 Introduction 
Manual validation of database search results have revealed several common sources of false 
positives including poor quality spectra, non-enzymatic cleavage, chemical or post-translational 
modifications, incorrect monoisotopic peak assignment, and incorrect charge state assignment 
[63,64]. While computational strategies have been developed to address a number of these 
sources (semi-tryptic searches, variable modification searches with common chemical 
modifications, isotope error correction in database search engines etc.), they are not 
comprehensive and are not always applied for large datasets due to the computational costs 
involved. In proteogenomics contexts where the presence of false positives is of much greater 
concern, these additional computations might be necessary for successful identification of novel 
peptides.  We developed a computational framework for annotating and quantifying the false 
positives that might be avoided using more extensive analyses. Finding a large number of high 
confidence false positives is inherently difficult as they are indistinguishable from true positives 
on the basis of database search and peptide validation scores. Fortunately, the use of the target-
decoy strategy [50] provides us with a mechanism to study false positives as decoy assignments 
are incorrect by design. We performed peptide identification using three database search engines 
[34,36,38] and a blind modification search tool [41] in both tryptic and semi-tryptic modes to 
quantify the false positives that are due to ambiguous assignments, semi-enzymatic cleavage, and 
modified peptides. 
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Next, we took a deeper look at modified peptides to see how they cause false positives and 
whether such false positives are correctly modeled by the target-decoy strategy. While blind 
modification search tools can identify modified peptides with unknown modifications, they 
suffer from reduced sensitivity and are often incompatible with other tools in common 
proteomics workflows such as those for peptide validation. Hence, there was considerable 
interest in a recent report [65] exploring the feasibility of searches using wide precursor mass 
tolerances of hundreds of Daltons (open searches) to identify modified peptides using 
conventional database search tools. We applied the open searching concept to identify modified 
peptides and compared the identifications with those from a conventional narrow window search.  
2.2 Materials and methods 
2.2.1 Characteristics and sources of high scoring decoys 
Datasets and data preparation 
A publicly available dataset consisting of a panel of various triple negative breast cancer cell 
lines and tissue specimens analyzed on a Thermo Scientific Q Exactive mass spectrometer [66] 
was downloaded from ProteomicsDB (PRDB004167) in vendor .raw format.  The Thermo .raw 
files were converted to the mzML format using vendor provided centroiding and default 
parameters using the msconvert.exe tool from ProteoWizard (3.0.7398 64-bit version).  For the 
MODa analysis, the mzML files were further converted to the MGF file format from the mzML 
files using default parameters.  
 
A human protein database was retrieved from UniprotKB (download date: 2016-07-29) and 
appended with decoy proteins containing reversed peptide sequences (with prolines left in-place 
when they are immediately before a trypsin cleavage site to ensure that the distribution of tryptic 
peptide masses is identical between the forward and decoy space).  Common contaminants 
(cRAP protein sequences from GPMDB and contaminants from MaxQuant) were appended to 
the concatenated protein database. 
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Peptide identification pipeline 
Peptide identification was performed independently using three different database search engines 
(Comet[34] 2015.02 rev 1, X! Tandem[36] 2015.04.01.1, MS-GF+[38] v10089) and a blind-
modification search tool (MODa[41] v1.51) against the protein database described above in both 
fully tryptic and semi-tryptic modes.  For all searches, trypsin was specified as the enzyme used 
for digestion with the precursor mass tolerance set to 20ppm.  Static carboxyamidomethylation 
(+57.021464 Da) on cysteine was specified for all tools while oxidation (+15.9949 Da) on 
methionine and N-terminal acetylation (+42.0106 Da) were specified as variable modifications in 
the three database search engines.  For Comet and X! Tandem, up to five missed cleavages were 
allowed (MS-GF+ does not limit the number of missed cleavages).  Parent isotopic error 
correction was enabled in all search engines (isotope_error = 1 in Comet and –ti “0,2” in MS-
GF+). In Comet, the use of neutral loss was disabled and high-resolution MS/MS settings 
(fragment bin offset 0.0 and fragment bin tolerance of 0.02) were used for scoring.  In X! 
Tandem, the top 100 peaks were used for scoring with a required minimum of 4 matched 
fragment peaks.  For MODa analysis, only a single modification was permitted per peptide with 
a modification range of -500 to +500 Da.  Fragment mass tolerance was set to 0.02 and the high-
resolution MS/MS mode was enabled. 
 
X! Tandem output files were converted to the pepXML format using the Tandem2XML tool 
found in the Trans-Proteomics Pipeline[67] (TPP) version 4.8.0.  MS-GF+ outputs were 
converted from mzIdentML to pepXML using idconvert from ProteoWizard (3.0.6002). 
 
Peptide validation and false discovery rate estimation 
Peptide validation was performed individually on each pepXML file in the six (three search 
engines; tryptic and semi-tryptic) sets of outputs using PeptideProphet[48]  (TPP 4.8.0) using the 
following settings: ‘d’ (report decoy hits), ‘A’ (high mass accuracy model), ‘E’ (use search 
engine calculated expectation values), ‘P’ (semi-parametric modeling), ‘PPM’ (parts per million 
in mass model).  For each set of analyses, the pepXML files corresponding to the 457 LC-
MS/MS runs were read using a custom Java program and false discovery rate estimation was 
performed empirically using the target-decoy approach at both the PSM level and peptide level 
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(using the high scoring PSM as a surrogate for peptide probability).  Spectrum level and peptide 
level q-values were assigned for each PSM. No FDR filtering was performed for MODa results. 
 
Integration of peptide identification results 
Data integration was performed by first normalizing the scan numbers output by the different 
tools. X! Tandem indices were 1 smaller than the ones reported by MS-GF+ and Comet while 
MODa reports scan numbers as the n-th MS/MS scan present in the MGF file starting at 1. 
PepXML files and MODa results were parsed and converted to a tab-delimited results file with 
search results for each spectrum query grouped together and numbered using the MS-
GF+/Comet scan numbering. 
 
Screening and interpretation of high scoring decoys 
PSMs and peptides were considered a high scoring (PSM and peptide q-values of 0.01 or less) 
decoy if they matched to a peptide that cannot be found in the forward sequence space for at least 
one of the three search engines operating in fully tryptic mode. The high scoring decoy is 
explained as an Ambiguous Scoring event if a high scoring forward hit is identified by some 
other search engine. If no such tryptic hit is found, the semi-tryptic search results are considered 
and a Semi-tryptic explanation is assigned if there is a high scoring semi-tryptic forward hit. 
MODa results are then examined to determine if there is a modified forward peptide that 
explains the spectrum.  If no alternate explanation is found for the high scoring decoy after these 
steps, it is labeled as Unexplained. 
2.2.2 Target-decoy assumption is violated by modified peptides and causes 
underestimation of error rates 
Datasets and data preparation 
A deep HEK 293 dataset[65] consisting of 24 LC-MS/MS runs analyzed on a Thermo Scientific 
Q Exactive mass spectrometer was downloaded from PRIDE (PXD001468).   Conversion of 
vendor .raw files to mzML was performed as previously described. 
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Peptide identification using MSFragger 
Narrow window (100 p.p.m.) and open (500 Da) searching was performed by MSFragger 
(version 20170103.0) [62] on the HEK 293 dataset against the Ensembl database as described in 
section followed by peptide validation using PeptideProphet (using the extended mass model) as 
described in section 3.2.2.  Identifications were filtered to 1% FDR at both the PSM and peptide 
level (using the highest PSM probability). 
 
Generation and database searching of theoretic spectra from modified peptides 
The database dump (2014-08-10) of GPMDB[68] was retrieved from their FTP site and parsed 
using a custom Java program to extract peptide observations from the peptides table.  The tryptic 
peptides generated from an in-silico digestion of the Ensembl 78 human protein database was 
filtered using the list of GPMDB peptide observations to obtain a list of 282,806 peptides.  This 
list of peptides was further filtered to a set of 73,002 peptides by retaining only peptides that 
have a methionine residue. A random methionine is selected in each of these peptides and is 
oxidized in-silico and a theoretical spectrum is generated (with carbamidomethylated cysteines) 
consisting of singly charged b- and y-ions. The theoretical spectra are written to MGF files with 
the precursor mass and charge reported in the 2+ state.   
 
Peptide identification was performed using the Comet search engine (version 2015.01 rev. 1) 
against the same Ensembl 78 protein database (both with reversed protein decoys and reversed 
peptide decoys) using a 20 p.p.m. precursor mass tolerance in high resolution mode 
(fragment_bin_offset of 0.0 and fragment_bin_tol of 0.02). Fully tryptic digestion was specified 
with up to 1 missed cleavage and the use of neutral loss ions was disabled for scoring. Variable 
modifications were disabled as intended and static carbamidomethylation was specified for 
cysteines. Peptide identifications were ordered by their expectation value and binned into 1000 
bins to calculate the fraction of target matches in each bin. 
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2.3 Results 
2.3.1 Characteristics and sources of high scoring decoys 
We performed fully tryptic searches using three search engines [34,36,38] and applied a 1% FDR 
filter at both the peptide and PSM level. The target-decoy strategy assumes that incorrect 
assignments would match randomly to both targets and decoys. Yet the randomness to which 
these incorrect assignments are matched to decoy peptides is not well understood and the 
presence of multiple PSMs supporting the same peptide remains a common filter for additional 
stringency in proteomics analyses. While the majority of decoy peptides are only supported by a 
single high scoring PSM, there are many that are supported by tens or even hundreds of PSMs, 
independent of the search engine used (Figure 2-1).  The fact that certain decoy peptides can be 
supported by hundreds of PSMs suggest that the same is likely to hold true for false positives and 
that even if a forward peptide is supported by hundreds of high scoring PSMs, it may still be a 
false positive. The non-uniform nature of these decoy matches across the decoy space indicates 
that they originate from unaccounted peptides rather than random chemical noise. 
 
 
Figure 2-1 High scoring decoys can be supported by tens to hundreds of PSMs.  
High scoring decoy peptides are grouped based on their number of supporting PSMs for each of the three search engines 
operating in fully tryptic mode. 
Next, we examined the overlap in high scoring decoy peptide identifications across the three 
search engines. 7,313 high scoring decoy peptides (at 1% peptide FDR) were identified across 
the three search engines (Figure 2-2). Surprisingly, only 107 decoy peptides identified by all 
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three search engines. The vast majority (6,576) of high scoring decoy peptides were only 
identified by a single search engine. The lack of agreement between the different search engines 
illustrates differences in their spectrum similarity and score calibration functions as the same 
spectrum is either assigned to another incorrect peptide or fails to reach statistical confidence to 
pass the 1% FDR filter. This lack of agreement can also be used to improve peptide 
identifications by combining orthogonal scoring functions in these search engines and removing 
borderline or conflicting identifications. Indeed, this concept has been used with much success in 
peptide validation for reducing error rates and improving the number of identifications at a given 
FDR [69,70]. 
 
 
Figure 2-2 Overlap of decoy peptide sequences across three search engines.  
High scoring decoy peptide sequences are compared across three search engines. The vast majority of decoy sequences are 
unique to a particular search engine. 
As these incorrect assignments are likely due to unaccounted peptides, we expanded the search 
space by performing semi-tryptic searches using the three search engines and a blind 
modification tool [41] to account for unanticipated chemical or biological modifications. We also 
considered instances where identification is ambiguous – cases where a forward peptide and a 
decoy peptide are both identified with high confidence by two different search engines. These 
may represent situations where the database search engine is overly confident in its assignment. 
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Figure 2-3 Explanation of high scoring decoy PSMs.  
High scoring decoy PSMs are iteratively explained using fully tryptic, semi-tryptic, and blind modification search results. 
 
We attempted to find explanations for high scoring decoy PSMs in the following order: 
ambiguous scoring by the presence of a high scoring forward PSM identified by another search 
engine, semi-tryptic by the presence of a high scoring semi-tryptic forward PSM identified by 
any search engine, modified peptide if MODa nominates a modified forward peptide, and 
unknown if we fail to find a possible explanation for the high scoring decoy PSM (Figure 2-3).  
In 38.83% of high scoring decoy PSMs, they can be explained by an ambiguous scoring event. 
For example, the decoy peptide IVESITK was identified with confidence in 286 PSMs. In many 
cases, the forward peptide LVTDLTK was identified by another search engine. Comparing the 
matched fragment ions for the two different peptide assignments in one such experimental 
spectrum (Figure A-1) shows that the matched fragments are identical in mass and that outside of 
auxiliary information (such as knowledge of the fragmentation pattern or additional fragments 
from neutral loss ions), the two identifications are of equal confidence and we lack experimental 
information to distinguish between the two.  While the fragments are measured with high mass 
accuracy and match to a large number of theoretical fragment ions, the presence of multiple 
peptides that match equally well highlights the difficulty in confidently identifying short 
peptides.  
 
Next, we examined the population of decoys that can be explained by a semi-tryptic peptide. 
13.39% of high scoring decoy PSMs was confidently identified as a semi-tryptic peptide. In our 
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example (Figure A-2), the spectrum matching decoy peptide LANLLVGK was reassigned to the 
semi-tryptic forward peptide LAGGIIGVK in a semi-tryptic search. The semi-tryptic match 
improved upon the decoy match by matching two additional y-ions of relatively low intensity. 
While the correct identification may well be the semi-tryptic assignment, the large number of 
matched high intensity fragments in the decoy assignment once again demonstrates the 
limitations of current similarity scoring functions as there is little information to distinguish 
between the two matches.  
 
We then examined the 27.44% of decoy PSMs that are explained by chemical or biological 
modifications. We posit that this percentage may be heavily dependent on sample complexity 
and instrument acquisition speeds. In more complex samples, abundant unmodified peptides 
dominate the peptide ions that are sampled by the mass spectrometer while less abundant 
modified forms are ignored. The converse is true for fractionated or low complexity samples 
with few proteins giving modified peptides a greater chance to be sampled. Increasing the 
acquisition speed of the instrument or the runtime of the LC-MS/MS run will also likely increase 
the number of modified peptides sampled and correspondingly, the number of high scoring 
decoys (and false positives) that are due to unaccounted modifications. In the selected example, 
the decoy assignment EWHHSHTDITLR fails to match many of the high intensity fragment 
peaks while the modified peptide assignment of IW[16]HHTFYNELR (oxidation on tryptophan) 
is of much higher quality, explaining nearly all of the intense peaks in the fragmentation 
spectrum (Figure A-3). While tryptophan oxidation is well known, it is often not included in 
routine peptide identification workflows due to the analysis time required to consider additional 
variable modifications. This demonstrates the utility of blind modification search tools for 
improving peptide identifications even when the identification of modified peptides is not the 
primary goal as they have the ability to eliminate false positives. However, many blind 
modification search tools are slow and incompatible with conventional peptide identification 
workflows. 
 
Finally, there remains 20.34% of decoy PSMs that cannot be explained by any of the above 
analysis. As they are assigned to some decoy PSM with high confidence, they contain peptide 
fragments and are likely of peptide origin. As they cannot be explained as semi-tryptic peptides 
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or modified peptides from the reference proteome, they may be ions with incorrect charge state 
assignment, peptides derived from alternative splicing [7], peptides with no enzyme specificity 
[71], or even proteasome spliced peptides [72].   
 
Together, these results suggest that improvements to similarity scoring functions are needed to 
resolve ambiguous assignments and that proper accounting for all peptide forms (semi-tryptic 
and modified) is necessary for confident peptide identifications. 
2.3.2 Target-decoy assumption is violated by modified peptides and causes 
underestimation of error rates 
High prevalence of peptides identified in modified form only 
To further explore the idea that certain false positives are due to modified peptides, we 
performed both narrow window and open searching (to account for modified peptides) on a HEK 
293 dataset (both searches done without variable modifications). We reason that false positives 
that are due to modified peptides would be confidently identified in the narrow window search 
(as a false positive) but not in open search (as the supporting spectra would now be assigned to 
their correct modified peptide identification). To investigate, we looked at the intersection of 
search results (at the unique peptide level) by subdividing the peptides on the basis of their 
estimated confidence (Figure 2-4a) and examined the group-specific FDR.   
 
As expected, peptides that were accepted at 1% FDR in both searches (101,138 in total) were of 
high confidence, with an estimated FDR of 0.15%. Peptides found in both searches but accepted 
only at 1% FDR in one of the two searches were of lower confidence, as evidenced by the 
increased group FDR. Of greatest intrigue to us, however, were the peptides that were 
confidently identified in one search but were not identified at all in the other. 
 
There were 12,622 peptides confidently identified in open search but not in narrow-window 
search. The relatively low group FDR of these peptides (4.15%) suggests that most of these are 
bona fide examples of peptides that were only detected in modified forms. The substantial 
number of such peptides is problematic for ‘dependent-peptide’ approaches for PTM 
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identification [73] (including spectral library-based methods) [74,75] that rely on co-
identification of the unmodified peptide. A comparison of the modification profile of these 
peptides to one that is generated from all modified peptides shows high similarity (Figure 2-4b), 
suggesting that most of these identifications correspond to constitutive or highly abundant 
modifications. 
 
 
Figure 2-4 HEK293 peptide identifications across traditional narrow-window and open searches demonstrate 
underestimation of FDR. 
Peptides are subdivided on the basis of their estimated confidences in both open and narrow-window search. Group-specific FDR 
values are estimated using decoys within each group. (b) Mass difference profiles in open search for spectra that identified a 
peptide unique to narrow-window search (red) or open search (purple) and for all spectra (boxed). (c) Supporting PSM counts in 
narrow-window and open search for conflicting peptide identifications involving a peptide found only in narrow-window search 
(at 1% FDR). (d) Comparison of peptide categories passing 1% FDR in narrow-window search. (e) Target and decoy matches in 
narrow-window search for spectra identified with a common modification in open search. 
 
Open searching uncovers FDR problem in traditional narrow-window searches 
In contrast, the 3,773 peptides identified in narrow-window search but not in open search had a 
much higher group FDR, of 14.68%. We mapped the spectra supporting these identifications to 
their results in open search. Of particular interest were spectra that were assigned to unmodified 
peptides in narrow-window search but reassigned, owing to an improved match, as modified 
peptides (with different sequence) in open search. These cases represent potential instances of 
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false positives in narrow-window search that are caused by chemical or biological modifications 
[76,77]. In each such instance—a pair of peptides whose masses differ by the mass of the 
modification detected in the open search—we compared the total number of supporting PSMs 
associated with the peptide sequence matched in narrow-window search to that in open search 
(Figure 2-4c). Assuming that peptides supported by a greater number of PSMs are more likely to 
be true identifications, we found substantially more support for the peptides identified in open 
search. Only 17% of the spectra were assigned to peptides that had greater support in narrow-
window search, whereas 68% had greater support for their open-search assignment. 
We called peptide identifications found only in narrow-window search to be ‘suspect’ (potential 
false positives) if there was greater support for the open-search assignment for each supporting 
PSM. Of the 3,773 peptides found only in narrow-window search, 1,139 were suspect. This is 
significantly more than the number of decoys (554) in the same group, and more than the total 
number of decoys in the entire narrow-window search, at 1% FDR (1,091 decoys in total). This 
suggests that false positives in narrow-window search are not correctly estimated by decoy 
peptides. Notably, some of these suspect peptides had very high scores (Figure 2-4d). 
 
We sought to verify the finding that the target–decoy strategy does not effectively capture false 
positives due to unaccounted modifications. We selected high-scoring peptide identifications in 
open search that were observed in both unmodified form and with a mass shift corresponding to 
a common modification (oxidation or carbamylation). As we did not specify any variable 
modifications, the target-decoy assumption is that spectra from these modified peptides would 
match equally (and incorrectly) to both targets and decoys in narrow-window search. However, 
that was not the case, as the rate of matching to target sequences was roughly six fold that of 
decoys for carbamylated peptide spectra, and more than nine fold for oxidized peptide spectra 
(Figure 2-4e). The violation of the target–decoy assumption is probably due to homology 
between true peptide sequences and other peptides in the target space, which we previously 
noted in the context of proteogenomics [7,76]. Further supporting this, the modification profile 
of peptides identified in open search and whose spectra produced suspect identifications in 
narrow-window search markedly lacked phosphorylation and aminoethylbenzenesulfonylation 
(Figure 2-4b). These two mass shifts (79.97 and 183.04 Da) are difficult to represent, as some 
sequence of amino acid addition and deletion. Overall, our analysis with the HEK293 data set 
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demonstrates that accounting for all modified peptide forms using the open-search strategy of 
MSFragger may be important for confident peptide identification, even when the identification 
of modified peptides is not the primary interest. 
 
 
Figure 2-5 Spectral homology in theoretical spectra derived from modified peptides. 
PSMs of theoretical spectra derived from a peptide with oxidized methionine are ordered by their expectation value and binned to 
calculate the fraction of target hits as a function of expectation value (a) Analysis performed using reversed protein sequence as 
decoys (b) Analysis performed using reversed peptide sequences as decoys 
Validation of target-decoy violation using theoretical modified spectra 
While the searching of experimental spectra identified as modified peptides in a narrow window 
search suggested that the target-decoy assumption is violated, we must proceed with caution due 
to the confounding problem of chimeric spectra. In some cases, a modified peptide (the top 
identification in open search) can be co-fragmented with an unmodified peptide which is then 
identified (correctly) in the narrow window search that does not account for modifications. To 
circumvent the problem of chimeric spectra, we generated theoretical spectra for a set of peptides 
with oxidized methionine.  As expected, for the majority of these theoretically pure spectra, they 
map to both targets and decoys at equal rates. However, for the highest scoring matches, there is 
a strong preference for target sequences, regardless of the method used in decoy generation 
(Figure 2-5). Unsurprisingly, some of the highest scoring PSMs are due to single amino acid 
differences that are equal to the mass of the added oxygen atom (e.g. alanine to serine in 
M[16]ASTFIGNSTAIQELFK matches MSSTFIGNSTAIQELFK with e-value 3.62E-20). There 
are also examples where the peptides differ in the number of amino acids but remain spectrally 
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similar (e.g. M[16]DVNVGDIDIEGPEGK matches NSHHSWEPLDAPEGK with e-value 
4.71E-8). Together, these results show that modified peptides can be potential sources of false 
positives that are not well modeled by the target-decoy strategy. 
2.4 Discussion 
In this chapter, we demonstrate that nearly 80% of high scoring false positives can be explained 
through additional computational analysis. Nearly half of the explainable false positives can be 
attributed to ambiguous identifications where there is a lack in search engine concordance. This 
suggest that combining results from multiple search engines [69] or similarity scoring functions  
might help in identifying these cases and reducing their assigned confidences. It also points to 
limitations in the scoring functions presently used in database search engines where only a 
rudimentary model for predicting theoretical spectra is used (equal ion intensities). The use of 
spectral libraries generated from synthetic peptides [78] or fragment ion intensity prediction 
programs [32,79] may help resolve such ambiguities and reduce the rate of such false positives in 
the future. The high confidences with which these ambiguous identifications are reported may 
also be a consequence of the availability of high mass accuracy data in both MS1 and MS2, 
where a few matched fragment ions result in high confidences due to a reduction in fragment 
matches of a purely random nature. The other half of explainable false positives are due to 
peptides that are excluded (semi-tryptic and modified peptides) from searches due to 
computational costs or otherwise complexity in integrating different search results. While the 
computational costs associated with database searching can be readily addressed, new statistical 
models may need to be implemented to integrate multiple search spaces, each with different prior 
probabilities and selecting the explanation with highest posterior probability, to avoid a loss in 
sensitivity when vastly expanding the search space.  
 
The comparison between open and narrow window search results provides several insights into 
the properties of modified peptides and their impact on the production of false positives and error 
rate estimation. Over 10% of the peptides identified were identified only in modified forms, 
suggesting that methods which can directly identify modified peptides without co-identification 
of the unmodified peptide (such as tag-based PTM search tools or the open search strategy) are 
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likely to be the most successful in comprehensive identifying modified peptides and reducing the 
number of false positives. Second, both the experimental and theoretical results indicate, to 
varying degrees, that the target-decoy assumption is violated for modified peptides and that 
modified peptides are more likely to match to target sequences than decoy sequences, causing an 
underestimation of false positives that are due to modified peptides. The true extent of this 
violation is of much interest and further experiments using experimental spectra while 
accounting for the effects of co-fragmentation are needed. It is also important to note the 
limitations of this study and its generalizability to proteogenomics results. Open modification 
searching identifies only 50% of common modifications when compared to direct interrogation 
using specified variable modifications [65]. The underreporting of modified peptides may imply 
that the number of false positives due to modified peptides may be greater than what was shown 
in this study. Furthermore, the database searched in this comparison was the Uniprot protein 
database with few variant peptides or peptides that are highly homologous to one another 
compared to a database produced in a sequencing experiment. Hence, the error rates for such 
variant peptides could potentially be higher than what is estimated here. Experiments with 
decoys designed to contain single amino acid substitutions (confirmed not to exist from 
sequencing data) would allow us to directly interrogate errors of this nature. 
2.5 Data availability 
Raw mass spectrometry files are available from public repositories as described. The processed 
data files supporting the findings of this study are available upon request. 
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CHAPTER III 
EFFICENT DATABASE SEARCH TOOLS FOR 
PROTEOGENOMICS ANALYSIS 
Portions of this chapter detailing the MSFragger algorithm have been published in Nature 
Methods [62] 
3.1 Introduction 
Database search has long been a bottleneck in computational proteomics workflows [20] with 
continual efforts to improve the speed of identifications to match the pace of instrument 
acquisition speeds and the growth of protein databases. In proteogenomics experiments, the 
database to be searched is nearly 10X larger than a reference database, increasing the search time 
accordingly. Due to the already large search space that decreases sensitivity and long search 
times, semi-tryptic searches and multiple variable modifications are not commonly used. As 
demonstrated in the previous chapter, this can lead to an accumulation of false positives when 
peptide species present in the sample are unaccounted for in the search space. Further 
compounding this problem is the increasing popularity of the open search approach for 
identifying blind modifications. While simple in its approach (a matter of changing the precursor 
tolerance to hundreds of Daltons), it is a brute force approach, comparing each experimental 
spectrum to hundreds of thousands of candidate peptides. This leads to analysis times of over 50 
central processing unit (CPU) hours (per LC-MS/MS run) [62] using conventional database 
search tools, making it costly for large scale analyses. Hence, there is need for faster, more 
efficient database search tools for proteogenomics analysis. 
Computational advances in database search tools often fall in two orthogonal avenues. The first 
utilizes more advanced or sophisticated computing hardware such as parallel computing 
technologies such as networked compute clusters [80–82] to distribute the computation workload 
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on conventional processors or repurposing specialized hardware such as graphical processing 
units (GPUs) found in commodity graphics cards [83–85]. The second involves algorithm 
improvements that reduce the amount of computation needed to obtain peptide identifications of 
similar quality. This can involve strategies for using heuristics to filter the search space [36,40], 
improved implementations of scoring functions [86,87], or peptide indexing methods that 
eliminates redundant peptides and recycles the results of in-silico digestion [88,89]. In this 
chapter, we present two database search tools. The first, EGADS, utilizes GPUs to accelerate 
both in-silico digestion and similarity scoring while the second, MSFragger, uses a novel 
fragment ion-indexing scheme to vastly improve the speed of spectra similarity calculations. 
Algorithms that utilizes networked compute clusters can perform high-throughput searches but 
do not reduce the overall amount of computation time required considering all CPUs, making 
them costly and financially prohibitive for large-scale analyses. GPUs have been used as a more 
efficient alternative in many scientific applications as they offer the compute capabilities of 
hundreds of CPUs in a graphics card costing several hundred dollars. These GPUs consist of 
thousands of processing cores coupled to fast onboard memory. However, specialized algorithms 
are needed to function on GPUs due to the limited memories and single instruction multiple data 
(SIMD) nature of GPU cores where each individual processing cores must perform the same 
operation in lockstep but on potentially different pieces of data. Due to these complexities, GPUs 
have only been applied to the spectra similarity scoring step of database search [83,85] which has 
is more easily parallelizable and is historically the more computationally intensive step of 
database searching with low precursor mass accuracies. However, with high resolution 
instruments that records precursor masses with accuracies on the order of several parts per 
million [26,27], in-silico digestion may become a bottleneck when only similarity scoring is 
accelerated. Hence, EGADS implements both GPU accelerated digestion and scoring providing 
significant speedups regardless of the precursor mass accuracy. 
 
The growing popularity and ease-of-use of the open searching strategy for identifying modified 
peptides precipitated the development of MSFragger. Open searching using a 500Da window can 
take nearly 1000X longer than traditional narrow searches with a precursor tolerance in the tens 
of p.p.m. [62]. The use of traditional search engines is computationally prohibitive on large 
datasets and GPUs are not widely or inexpensively available from cloud providers. Hence, using 
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the relatively large amount of system memory, we developed a fragment ion indexing scheme 
that allows similarity scoring to be rapidly performed simply by traversing the index using 
experimental fragment ions. 
3.2 Materials and methods 
3.2.1 EGADS an Efficient GPU-Accelerated Database Search tool 
EGADS development environment 
EGADS was developed in C++ using Visual Studio 2010 on Windows 7 64-bit.  OpenCL 
support was provided by the AMD APP SDK (version 2.9). Testing was performed on a desktop 
computer equipped with an Intel 2500K processor with 16GB of memory with an AMD Radeon 
7950 GPU with 3GB of memory (using the latest AMD drivers as of May 2013).  
 
Datasets and data preparation 
A HeLa dataset [22] consisting of 3 technical replicates each with 6 fractions analyzed on a 
Thermo Scientific Orbitrap Elite was downloaded from PRIDE (PXD002395).  Vendor raw files 
were converted to MGF using ProteoWizard as previously described.  The human protein 
database was obtained from Refseq (release 55) and reversed protein sequences were appended 
as decoys.  For the scenarios involving a hypothetical proteogenomics use case, an mRNA 
database was obtained from Refseq (release 55) and was translated into a protein database using 
three-frame translation.  ORFs shorter than 10 amino acids were discarded in this translation. 
 
EGADS algorithm 
(1) Spectra input and pre-processing 
EGADS reads MS/MS spectra in MGF format and pre-processes them according to the chosen 
similarity scoring function after filtering the input spectrum to the specified top N peaks after 
filtering out peaks with m/z greater than 2048 (as EGADS calculates the Xcorr function using 
2048 bins).  For the Xcorr scoring function, an offset of 0.4 Da is added to the m/z of each input 
peak before binning to unit m/z bins (the maximal intensity is taken when there are multiple 
peaks that fall within the same bin).  The 2048 bins are then subdivided into 16 equal windows 
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and intensities within each window are normalized so that the maximum intensity within each 
window is 50.  The intensities are then transformed into the form necessary for fast cross-
correlation [86] by computing cumulative sums.  For PeakMatch and PeakBackground, no 
binning is performed.  PeakMatch normalizes the peak intensities so that the maximum intensity 
is 100, while PeakBackground performs the local normalization as performed in Xcorr using the 
ranges of 64 m/z but without binning.  
 
(2) Trial digestion and scoring 
EGADS performs in-silico digestion and simulated scoring (where the number of similarity 
scores required is calculated but the scoring is not actually performed) on a small region of the 
database (20 blocks of 4096 characters) to estimate the amount of GPU memory necessary to 
perform on-GPU digestion and scoring for a given amount of sequence space.  EGADS then uses 
this estimate and the available GPU memory (after accounting for the space necessary to store 
the database and experimental spectra) to partition the sequence space that can be independently 
analyzed in multiple digestion-scoring cycles (Figure 3-1). 
 
(3) In-silico digestion and peptide de-duplication 
EGADS performs in-silico digestion by first concatenating all proteins (separated by end-of-
protein delimiters) into a single string representing the entire sequence space.  The string is then 
subdivided into blocks of 4096 characters that can be analyzed by a single workgroup.  
Individual threads scan overlapping ranges of 128 characters in order to determine the number of 
digested peptides that starts within the first half of its range.  These counts are then summarized 
in scan operations and used to allocate appropriate memory for storing masses and offsets of 
these digested peptides.  The process is repeated to store the digested peptide products. 
 
Peptides are then optionally de-duplicated (within the same digestion-scoring cycle) to eliminate 
redundant peptides and the number of repeated similarity scoring calculations.  We re-pack the 
digested sequence into a 160-bit integer that is unique for all peptides less than 32 amino acids in 
length (the upper limit in EGADS).  This integer is then iteratively sorted 32 bits at a time using 
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a GPU-efficient version of radix sort [90] (which is also used for other sorting operations within 
EGADS)  grouping redundant peptides together in this sorted list.  
 
Next, peptides are expanded into modified mass peptides that represent the different masses that 
arise as a result of user specified variable modifications and are sorted by mass.  For each 
modified mass peptide, we also compute the number of structural isomers.  Peptides that produce 
more than 100 (hard coded limit that can be changed) modified versions of that peptide are 
considered not modified (modifications are ignored). Together, these elements form a peptide 
index for the current digestion-scoring cycle. 
 
(4) Similarity scoring and result reporting 
In GPU accelerated scoring, all threads within the same workgroup operate on the same 
experimental spectrum. The number of structural isomer, along with the number of experimental 
spectra that have a mass within the precursor mass window, are used to compute the number of 
workgroups necessary for scoring.  This information is then used to launch one of three scoring 
kernels that are responsible for computing the peptide-spectrum similarity scores. Lookup tables 
are used to efficiently map permutations to modified residues. 
 
Three scoring kernels were implemented that mimics modes in popular database search tools: 
Xcorr (unit-resolution Comet [34]), PeakMatch (computes hyperscore as in X! Tandem [36]), 
and PeakBackground (high-resolution Comet).  Xcorr is computed a simple product after spectra 
pre-processing described above while PeakMatch and PeakBackground is calculated using 
sliding windows to merge the peak lists between the experimental and theoretical spectrum in 
time linear to the total number of peaks.  
 
Similarity scores are transferred back to the CPU where a histogram of scores and a heap of the 
top hits are maintained for each experimental spectrum.  The similarity scores are converted in a 
scoring function dependent manner to an expectation value.  Results are written to a pepXML 
file that is compatible with PeptideProphet by masquerading as either Comet or X! Tandem. 
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Figure 3-1 Architecture of EGADS. 
EGADS performs trial digestion and spectra pre-processing on the CPU before starting digestion-scoring cycles on the GPU. (b) 
Results are transferred back to the CPU where the histogram of scores for each spectrum is modeled and an expectation is 
calculated for the reported hits. 
 
Timing and Performance Measurements 
Timers are placed throughout EGADS to collect timing information on the cumulative time spent 
in individual steps of the database search process.  Database search implementations can vary 
widely so comparing runtimes between different database search engines is not meaningful for 
determining the extent of GPU acceleration.  Hence, EGADS implements identical data 
structures and algorithms used in the OpenCL kernels in C++ (referred to as EGADS CPU) so 
that the same parallel algorithms that are run on the GPU can be run serially on the CPU. 
EGADS does not make use of CPU-GPU concurrency as all OpenCL calls made are blocking. 
 
For timing purposes, we consider digestion to be the steps in the digestion-scoring cycle up to 
the point of counting structural isomers and scoring to be remaining steps in the cycle, including 
update of the results structure.  Input, initialization (including compilation of the OpenCL 
kernels if no cached version exists), spectra conditioning and pre-processing, and output takes no 
longer than several seconds in total and is not a major factor in overall runtime. 
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Benchmarking of EGADS on a HeLa dataset 
Peptide identification benchmarking was performed by searching the Refseq 55 protein database 
(described above) allowing for 1 missed cleavage in fully tryptic digestion.  Static 
carboxyamidomethylation (+57.021464 Da) on cysteine was specified while allowing oxidation 
(+15.9949 Da) on methionine to be a variable modification.  The permitted peptide mass range 
was 500-2000 Da (results were filtered to exclude matches outside this range in X!Tandem 
where the maximum cannot be specified).  The precursor mass tolerance was set to 100ppm with 
fragment mass tolerance set to 20ppm (0.02 Da bins for Comet). Isotope error correction was 
disabled.  The use of neutral loss ions was disabled in Comet.  For EGADS and X! Tandem, the 
top 50 fragment ions was used in searching.  EGADS was given access to 2GB of memory using 
the PeakMatch scoring kernel.  Run time benchmarking was performed using the above settings 
(except Comet was run in unit-resolution mode for the comparison with Xcorr), varying the 
digestion mode, precursor window, and scoring kernel.  Apart from the identification rate 
benchmarking, all analyses was performed on the run 20100611_Velos1_TaGe_SA_Hela_1. 
 
Peptide validation was performed using PeptideProphet [48]  (TPP 4.8.0) using the options d’ 
(report decoy hits), ‘A’ (high mass accuracy model), ‘P’ (semi-parametric modeling), ‘PPM’ 
(parts per million in mass model) and FDR was estimated empirically using the target-decoy 
approach after ordering PSMs and peptides (represented by highest scoring PSM) by 
PeptideProphet probabilities. 
 
Combinatorial evaluation of GPU acceleration 
Evaluation of GPU acceleration in diverse search applications was performed by varying the 
following search parameters: de-duplication (on / off), phosphorylation search (on / off), 
precursor mass tolerance (20 ppm / 1 Da), and sequence space (Refseq 55 protein / 3-frame 
translated Refseq 55 RNA), digestion mode (tryptic with 1 missed cleavage, semi-tryptic with 1 
missed cleavage, non-specific), and similarity function (Xcorr / PeakMatch / PeakBackground).  
All other search parameters were set to the values described above for benchmarking. EGADS 
was run in both CPU and GPU mode for each of the 144 search combinations.  Runs taking 
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longer than 4 hours on the CPU was killed and excluded from the analysis (66 out of the 144 
combinations completed successfully). 
 
Benchmarking memory effects on EGADS runtime 
For evaluation of the memory effects on EGADS runtime, the Refseq protein database described 
above was searched using EGADS running in GPU mode using all three digestion modes (fully 
tryptic, semi-tryptic, and non-specific). For each memory limit (1024MB, 1536MB, 2048MB, 
and 2560MB), five runs were performed and the average runtime calculated after discarding the 
shortest and longest runs. 
 
Open database searching using EGADS 
The PeakMatch scoring algorithm was modified to include two additional ion series: b + ∆ and y 
+ ∆ to account for any shifted fragment ions due to a modified residue in open searching.  ∆ is 
computed as the difference between the experimentally observed mass and the theoretical 
peptide mass.   
 
MODa (version 1.23) was used in single blind mode with fragment mass tolerance set to 0.02 
and high-resolution MS/MS.  In both EGADS and MODa, static carboxyamidomethylation was 
specified. Variable oxidation of methionine was specified in EGADS but all results involving 
oxidized methionine were filtered out in both searches as there it was not possible to specify 
variable modifications in MODa.  The allowed modification range was -200 - +200 Da in both 
searches.  No FDR filtering was performed in the open search analysis. 
3.2.2 MSFragger implements a novel fragment ion index that enables ultrafast 
database search 
Datasets and Data Preparation 
A HEK 293 dataset[65] consisting of 24 LC-MS/MS runs analyzed on a Thermo Scientific Q 
Exactive mass spectrometer was downloaded from PRIDE (PXD001468).   Conversion of 
vendor .raw files to mzML was performed as previously described.  
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MSFragger algorithm 
(1) MSFragger spectra input and pre-processing 
MSFragger accesses mzXML and mzML files using MSFTBX, the Data Access Library 
provided as part of the BatMass [91] and Mascot Generic File (MGF) files using an internal 
parser.  These data input paths allow MS/MS spectra stored in any of the three file formats 
(mzXML/mzML/MGF) to be analyzed by MSFragger. Spectra pre-processing begins with linear 
scaling of peak intensities so that the most intense peak within each spectrum is set to 100,000. 
Resultant scaled intensities are rounded and stored as integers for fast arithmetic operations. The 
top N peaks from each spectrum are retained and are then filtered based on the minimum 
intensity ratio and the m/z range specified in the search parameters file. In this study, the top 100 
peaks with a minimum intensity ratio of 0.01 (relative to the base peak) were used with no m/z 
range filter. 
 
(2) In-silico protein digestion and peptide indexing in MSFragger 
MSFragger allows for fully enzymatic, semi-enzymatic, and non-enzymatic digestion to be 
specified as search parameters.  It also allows for limits on missed cleavages, peptide lengths and 
masses to be specified.  For a given protein database and a fixed set of digestion parameters, a 
peptide index is generated to form a necessary reference for the fragment index. Peptide indexing 
takes just a few minutes on a typical computer. Furthermore, MSFragger caches the peptide 
indices it generates on disk and attempts to find and use a compatible peptide index on 
subsequent invocations.  As the first step of in-silico digestion, all proteins are concatenated into 
one long amino acid sequence with proteins separated by delimiter characters. MSFragger then 
partitions this long amino acid sequence into chunks for parallel in-silico digestion into peptide 
sequences based on the specified digestion parameters.  Efficient memory allocation methods 
and compact representations of peptides (as offsets in the concatenated amino acid sequence and 
length) allow for fast in-silico digestion. The digested peptide sequences are then sorted using a 
parallel least significant digit radix sort and redundant peptides are flagged by comparing 
adjacent peptide sequences in the sorted list of peptides. 
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Modified versions of the digested peptide sequences are then generated based on the user-
specified variable modifications. Combinatorial bitmasks that specify the positions of modified 
residues are pre-computed so that the set of variably modified residues can be specified as a 
single integer.  These sequence numbers are then combinatorially combined across all variable 
modifications to generate a single integer that represents the variable modification state of a 
peptide sequence. A 12-byte entry containing the offset, length, modification sequence number, 
and the modified mass is generated for each such modified peptide. These modified peptides are 
then sorted in parallel by their modified mass forming the MSFragger peptide index. 
 
(3) Fragment index generation 
The fragment index used in MSFragger consists of all theoretical b and y-ions up to a specified 
charge state from each peptide in the peptide index.  For efficient fragment index searching, the 
fragment bin width used for the fragment index must be proportional to the desired fragment 
tolerance specified in the search and to the expected number of candidate peptides encountered 
per experimental spectrum. Hence, MSFragger dynamically computes an appropriate bin width, 
in Daltons, that allows for efficient fragment index searching based on the user specified 
precursor mass tolerance and the fragment mass tolerance.  Each peptide entry in the peptide 
index, consisting of both unmodified and variably modified peptides, can be referenced by a 
single 32-bit integer identification number (ID), imposing a current limit of approximately 2 
billion peptide entries. Within each peptide entry, the theoretical fragments are generated and 
binned based on their masses using the determined bin width.  The theoretical fragments are 
stored within the fragment index as an 8-byte entry that references the parent peptide ID, the 
mass offset within the bin, the charge state, and the fragment ion identity (e.g. b-5 or y-2).  
Fragments within each bin are stored in order of their parent IDs (and hence the parent precursor 
mass) as the fragment index is generated in the order of the peptide index. The memory 
consumption of the fragment index is modest. For a tryptic digestion (with 1 missed cleavage) of 
the human UniprotKB database (with reversed decoys) used in the study, the fragment index is 
only 1.6GB.  Adding methionine oxidation and N-terminal acetylation of proteins as variable 
modifications boosted the index size to 2.9GB.  Examples of fragment index sizes (which 
includes the above common variable modifications) for larger search spaces include HLA 
peptides (non-enzymatic digest of 9-11 amino acids; 22.6GB), semi-tryptic peptides (55.8GB) 
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and variably phosphorylated peptides (86.5GB).    MSFragger identifies the amount of memory 
available to it via the Java Virtual Machine and automatically partitions the fragment index 
generation and search into multiple iterations based on projected memory required for the 
fragment index, storing intermediate results on disk before merging and outputting the results in 
the final pass.  This enables MSFragger to perform searches on computers that do not have 
sufficient memory to store the full fragment index, although at reduced speeds. In addition to the 
fragment index, MSFragger requires additional memory for storing the peptide index, spectra 
data, results, and intermediate data structures during search that is roughly 1GB in most use 
cases. 
 
(4) Fragment index searching 
In database search, the similarity scores are computed between each experimental spectrum and 
the theoretical spectra of all candidate peptides within a precursor mass range. These scores are 
heavily dependent on the number of shared fragment ions between the experimental spectrum 
and theoretical spectra. The major computational advance presented by MSFragger lies in its 
ability to rapidly identify these shared fragment ions and thus compute spectrum-spectra scores 
with near optimal efficiency.  MSFragger first identifies the number of candidate peptides using 
the precursor mass window and the computed peptide index. It then allocates a scoring table for 
each candidate peptide where the number and summed intensities of matched b and y-ions can be 
stored.  It then performs spectrum to spectra scoring using the fragment index in the following 
manner. Consider a fragment ion with mass M within an experimental spectrum with precursor 
mass P.  Using the fragment index, the algorithm can identify the theoretical spectra that contain 
a fragment with a matching mass by examining the fragment bins that overlap the interval [M – 
dF, M + dF], where dF is the fragment mass tolerance specified in Daltons or otherwise 
computed from M and the specified tolerance in parts per million (Figure 3-10).   
 
For each overlapping fragment bin, a binary search (recall that the fragments within each bin are 
ordered by their parent precursor masses) is used to identify the fragment within the bin that 
corresponds to precursor mass P – dP, where dP is the precursor mass tolerance.  The bin is then 
traversed and the theoretical fragments within the bins are compared to determine whether they 
truly lie within the fragment mass tolerance window, and if the theoretical fragment charge state 
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is compatible.  If a match is identified, the scores of the parent peptide (recall that each 
theoretical fragment contains a reference to its parent) are then incremented in the scoring table.  
This traversal continues until the end of the bin or upon arrival at a fragment with parent 
precursor mass greater than P + dP. The process is then repeated for each overlapping fragment 
bin.  At completion, this process using a single experimental fragment ion represents the 
contribution of that fragment ion to all spectrum-spectra scores. This process is repeated for each 
experimental fragment ion (Figure 3-10), in essence, decomposing many spectrum-spectrum 
matches into multiple fragment-spectra matches. After processing all experimental fragment 
ions, the scoring table of candidate peptides contains the number of matching ions (and 
intensities) and is used to generate a similarity score for each candidate peptide.  
 
The efficiency of this process lies in its ability to only examine fragments with a high likelihood 
of contributing to the similarity score. In conventional strategies, performing a comparison 
between an experimental spectrum and a theoretical spectrum can take tens or hundreds of 
operations, even in cases where they share no common fragments.  In the MSFragger strategy, 
theoretical spectra that share no common fragments are effectively bypassed (apart from reading 
a score of 0 from the scoring table) as mostly relevant fragments are compared. In the case of 
open window searching, approximately 1.5 comparisons are performed on average per candidate 
peptide and over 80% of fragment comparisons within the fragment index contribute to a 
similarity score (Figure 3-2).  This algorithmic advantage that allows MSFragger to perform so 
few comparisons in similarity calculations is the reason why it performs over 100 times faster 
than conventional search tools. 
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Figure 3-2 Fragment indexing allows efficient spectra similarity comparisons. 
The cost and efficiency of spectra similarity calculations can be approximated by the number of fragment comparisons required 
for each candidate peptide.  In conventional strategies, tens to hundreds of comparisons are needed to compare an experimental 
spectrum to a theoretical spectrum.  However, the vast majority of such fragment-fragment comparisons do not result in matches 
as the differences between their m/z is often far greater than the fragment mass tolerance.  Using MSFragger’s fragment index, 
these comparisons are omitted as the binning strategy allows us to retrieve only the experimental-theoretical fragment pairs that 
are close in m/z – the majority of which falls within the fragment mass tolerance and are deemed relevant when they contribute to 
the score of a PSM.  MSFragger’s alternative approach results in only a few fragments evaluated per candidate peptide across a 
variety of search scenarios.  Reduction in the fragment bin width allows for fewer fragment comparisons to be performed at the 
expense of computational overheads associated with traversing a greater number of bins that overlap the fragment tolerance 
window.  MSFragger dynamically selects a bin width appropriate for the search scenario (opting for smaller bins in open search 
where the number of comparisons is large, and larger bins in narrow window search, where the number of comparisons is small 
relative to the overhead costs).  Hence, a greater number of fragments is evaluated per candidate and a lower percentage of 
comparisons are found relevant in narrow window searching due to this optimization. 
 
Fragment index searching in MSFragger is highly optimized. Tradeoffs between the number of 
bins to traverse (cost of binary searching and other overhead) and hit efficiency (percentage of 
fragments that fall within the fragment mass tolerance) is weighted and considered in fragment 
bin width selection. The traversal algorithm is optimized for modern CPU cache sizes to reduce 
main memory accesses using a simultaneous traversal scheme for all experimental fragment ions. 
This allows for overall improved performance and reduces memory bottlenecks in multi-core 
systems (Figure 3-3). 
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Figure 3-3 MSFragger scales efficiently across large numbers of CPU cores. 
Indexing and searching operations in MSFragger are designed for modern multi-core computers and are optimized to reduce 
pressures on memory bandwidth.  Results are generated from open search times of a single LC-MS/MS run on a dual processor 
system with 14-cores in each processor. (a) MSFragger scales almost linearly in terms of overall search times on up to 8 cores.  
Reading of mass spectrometry data files and results compilation is not highly parallelizable resulting in reduced scalability 
beyond 8 cores.  The jump from 14 to 28 threads causes non-local memory to be accessed by each processor, impacting 
scalability.  (b) Fragment index searching by itself is efficiently parallelizable in MSFragger and scales to effectively utilize all 
cores. 
 
(5) Scoring and results reporting 
MSFragger computes a hyperscore similar to that of X!: 
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where Nb is the number of matched b-ions, Ny is the number of matched y-ions, Ib,© are the 
intensities of matched b-ions, and Iy,© are the intensities of matched b-ions.  While the theoretical 
fragment index can be adapted to include other fragment ion types, only b and y ions are 
included and used for scoring at this time. Expectation calculation is also performed in a similar 
manner as X! Tandem through linear regression of the survival function to estimate the 
expectation of a given hyperscore [92].  The top N results, as specified by the search parameters, 
are reported in a XML file in the pepXML format, which can then be processed using the tools 
from the Trans-Proteomics Pipeline (TPP) [67]. For use in other computational workflows, 
converters exist that can convert pepXML results into other standard data output formats. 
Alternatively, a simple tab separated values output of the results can be obtained instead of the 
pepXML. 
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Statistical modeling of MS/MS search results and protein inference 
X! Tandem, Comet, and MSFragger output files were uniformly processed by PeptideProphet 
[48] via the Trans-Proteomic Pipeline (TPP v4.8.0), followed by ProteinProphet [49] analysis to 
assemble peptides into proteins/protein groups. The results from the narrow window searches 
were processed using the following settings: PeptideProphet was run using ‘P’ (semi-parametric 
modeling), ‘d’ (report decoy hits), ‘E’ (calculation of posterior probabilities using search engine 
computed expectation values as primary peptide identification scores), and ‘A’ (high mass 
accuracy model), ‘PPM’ (use parts per million instead of Daltons in accurate mass binning), and 
the ProteinProphet was run using default settings. For open searches, several custom 
modifications were made to these downstream processing tools. First, PeptideProphet was run 
without ‘A’ and ‘PPM’ options, and using a mass accuracy model extended to cover the entire (-
1000Da to 1000Da) range (see Extended mass model below). Second, in ProteinProphet, we did 
not want to incorporate modified peptides in the determination of protein groups or the 
establishment of protein identities. Thus, ProteinProphet was adjusted to ignore any modified 
peptides, while being careful to retain peptide identifications that are likely triggered from C13 
isotope peaks of unmodified peptides.  
 
Extended mass model in PeptideProphet 
For open searches, the mass model of PeptideProphet was extended to effectively adjust for 
different likelihoods of obtaining a correct identification among unmodified peptides and 
peptides with different types of modifications (mass shifts). In brief, PeptideProphet models the 
distribution of scores observed in each data set as a mixture of two component distributions 
representing correct and incorrect identification, respectively. The key underlying assumption is 
a multivariate mixture distribution of the database search score (here, the expectation values 
produced by the search tools) and other parameters (most notably, the mass shift dM), which 
leads to the calculation of the probability of correct identification for individual peptide 
assignments by the Bayes rule. The mass shift parameter dM (which in the context of narrow 
window searches is referred to as mass accuracy ) is computed for each PSM as the difference 
between the calculated and measured precursor peptide masses [93]. Unlike narrow window 
searches, in open searches the range of possible dM values is extended, e.g. to cover (-1000 Da 
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to 1000 Da) range. The dM values are discretized into bins of 1 Da in size (centered at integer 
values). The distributions of database search scores and dM mass shifts are modeled 
simultaneously, resulting in the joint probability model and computation of posterior peptide 
probabilities. In doing so, the mass shift dM model is estimated from the data, defining 
likelihoods of observing a correct vs. incorrect identification among all PSMs belonging to a 
particular dM bin. As the main outcome, two PSMs with identical expectation values but having 
different binned dM values (e.g. 0 and 135) would receive very different probability scores, 
reflecting the fact that the estimated fraction of correct identifications in the dM ~ 0 bin (i.e. 
unmodified peptides) is much higher than that among peptides with a dM value around 135 Da 
(rare modification). Note that while the mass model helps to account for the differences in the 
likelihoods of observing unmodified peptides and different modified forms, coarse single Dalton 
binning fails to account for the parts per million (ppm) levels of accuracy present in these data 
from high mass accuracy instruments, and thus the model can further benefit from future 
revisions.   
 
Benchmarking analysis using HEK293 dataset 
For extensive benchmarking and comparison between MSFragger and other tools using HEK293 
dataset, all spectra were searched using MSFragger, X! Tandem (Piledriver 2015.04.01.1), and 
Comet (2015.02 rev.1).  Analysis was done using all files (24 LC-MS/MS runs, ~1.1 million 
spectra) for identification rate benchmarking, or one representative file for timing benchmarks 
(run b1906, 41820 spectra). The searched sequence database was created from the human protein 
sequences of Ensembl version 78 appended with reversed protein sequences as decoys and 
common contaminants (cRAP proteins sequences from gpmDB and contaminants from 
MaxQuant). All searches were done considering only y- and b- ions in scoring, allowing tryptic 
peptides only, up to 1 missed cleavage, and with cysteine carbamidomethylation specified as a 
fixed modification. Data were searched using either 100 ppm (narrow windows searches) or 500 
Da (open searches) precursor mass tolerances. X! Tandem search engine used the following 
algorithm-specific parameters: select top 50 peaks for fragment matching, 20 ppm fragment ion 
mass tolerance, and requiring at least 4 matched fragment ions for a PSM to be reported. Note 
that X! Tandem automatically considers three additional modifications (conversion to 
pyroglutamate from glutamine or glutamic acid, and N-terminal acetylation). Comet searches 
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were performed using recommended settings for high mass accuracy fragment data (precursor 
mass binning of 0.02 Da, 0 mass offset). MSFragger searches were performed using described 
parameters. To enable more accurate comparison with X! Tandem results, MSFragger searches 
(both narrow window and open) were also performed allowing same common modifications as 
those mentioned above for X! Tandem specified as variable modifications. For comparison with 
SEQUEST, the identification numbers (as listed in Table 3-3), i.e. the numbers of PSMs, unique 
peptide sequences, and proteins, were taken from the original publication [65]. 
  
For benchmarking the computational time (as listed in Table 3-3), MSFragger, Comet, and X! 
Tandem were also run using the single representative file referenced above on a quad core Linux 
workstation (Intel Xeon E3-1230v2). In addition, the data were searched using Tide (Crux 
version 2.1.16838), which only allows a maximum of 100Da mass tolerance and is single 
threaded. The run time for Tide, and for MSFragger run under the same constrains as Tide, are 
shown in Table B-1. For SEQUEST, the computational time listed in Table 1 was obtained by 
searching the data using the SEQUEST-HT version as implemented as part of the Proteome 
Discoverer v. 2.1 software, operated on a octa-core workstation (2x Intel Xeon E5-2609v2). The 
search parameters for SEQUEST-HT were as above, except the mass tolerance in the narrow 
window search was 5 ppm as in the original publication.  All computational time benchmarking 
results can be found in Table B-1. 
 
Comparison between MSFragger and MODa 
MODa (v. 1.51) was run in single-blind mode with a maximum modification size of 500 Daltons 
and a fragment tolerance of 0.02 Daltons.  Cysteine carbamidomethylation was specified as a 
static modification.  High resolution MS/MS search was enabled.  Tryptic digestion was 
specified with at most one missed cleavage.  Both fully tryptic and semi-tryptic searches were 
performed using MODa. FDR filtering was performed using the “anal_moda.jar” tool bundled 
with the MODa tool to achieve a FDR of 1%.  For comparison with MSFragger, we filtered the 
fully tryptic MSFragger open search results at 1% PSM FDR (without the 1% protein level filter 
that was used for the rest of the HEK293 benchmark comparison). 
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3.3 Results 
3.3.1 EGADS an Efficient GPU-Accelerated Database Search tool 
Framework for GPU-accelerated in-silico digestion 
In traditional database search tools, peptides are generated one at a time by traversing the protein 
database and experimental spectra within the precursor mass window are identified and scored.  
This process is simple and has minimal memory requirements but lacks the parallelism for 
efficient acceleration. In contrast, peptide indexing methods [37,94,95] decouples the in-silico 
digestion from similarity scoring by creating a sorted index of unique peptides prior to similarity 
scoring.  These methods have the advantage of eliminating redundant peptides and allow results 
of in-silico digestion to be re-used in subsequent searches if the index is stored (which may not 
be practical or efficient due to their size). In EGADS, we developed a hybrid strategy that takes 
advantage of the massive parallelism offered by the GPU to generate on-the-fly peptide indices 
that can be directly used for similarity scoring on the GPU in multiple digestion-scoring cycles 
(Figure 3-4).  
 
EGADS begins by partitioning the sequence space into chunks that can be processed within the 
limited GPU memory. It then performs in-silico digestion of the given chunk into individual 
peptides given the specified cleavage rules. These peptides then undergo an optional de-
duplication step to remove redundant peptides and are then expanded into multiple entries 
representing each modified masses that can be generated from variable modifications.  The 
entries are then sorted to create the peptide index.  Candidate peptides are then identified for 
each experimental spectrum and the number of scoring events is computed (by summing the 
number of structural isomers for each modified mass). The similarity scores are then computed 
in parallel and results are transferred to the host. At this point, the peptide index, along with all 
intermediate data structures, is discarded to free up GPU memory for the next digestion-scoring 
cycle (Figure 3-5). At the end of all digestion-scoring cycles, the results are summarized on the 
host and written to a file.  
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Figure 3-4 Digestion-scoring cycles in EGADS. 
In each digestion-scoring cycle, the partitioned database chunk is transformed in parallel to a peptide index on the GPU.  The 
peptide index is used for similarity scoring on the GPU. After the scores are reported to the host, the index is discarded to begin 
the next digestion-scoring cycle. 
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Figure 3-5 GPU memory usage of EGADS in digestion-scoring cycles. 
Memory allocation by EGADS is shown for a typical EGADS run. Each peak and trough represents one digestion-scoring cycle. 
 
Benchmarking of EGADS using a HeLa dataset 
We first compared the number of identifications that is obtained by EGADS to that of Comet and 
X! Tandem using a HeLa dataset.  At 1% FDR, EGADS (using the PeakMatch kernel) identified 
45,248 peptides (unique peptide sequences) and 225,228 PSMs. Comet and X! Tandem 
respectively identified 46,620 and 49,866 peptides, and 238,978 and 212,408 PSMs (Figure 3-6). 
Paradoxically, X! Tandem identified the fewest number of PSMs but the highest number of 
peptides.  This might be explained in part by the fact that X! Tandem has certain variable 
modifications that cannot be disabled which allows it to identify a greater number of peptides but 
the sensitivity of the cross-correlation function allows Comet to identify the greatest number of 
PSMs (with EGADS performing similarly as X! Tandem for PSMs as it also used the PeakMatch 
function but performs similar to Comet at the peptide level as it does not account for these 
additional variable modifications). Overall, EGADS performs similarly to these popular search 
engines and can reliably perform peptide identifications. 
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Figure 3-6 Identifications in the HeLa dataset as a function of FDR.  
Number of peptide-spectrum matches as a function of FDR.  (b) Number of identified peptides as a function of FDR. 
 
We then evaluated the runtime performance of EGADS, which is the primary focus of this study. 
We compared EGADS to Comet and X! Tandem using the Xcorr and PeakMatch functions 
respectively under different digestion modes and precursor tolerances (Table 3-1).  Comet only 
takes 1.6 times longer to perform a semi-tryptic search when compared to a fully tryptic search. 
Given the large difference in search space, this suggests that Comet spends a substantial amount 
of time in operations unrelated to digestion and scoring (such as input pre-processing).  In 
contrast, EGADS takes 16.4 times longer to perform the semi-tryptic search suggesting that it is 
much more efficient in input pre-processing. On average, EGADS GPU is 36.3X faster than 
Comet but much of that can be attributed to differences in input pre-processing as EGADS GPU 
is only 4.3X faster than EGADS CPU.  This highlights the importance in having a reference CPU 
implementation to ensure that implementation differences are not attributed to GPU-acceleration. 
In the PeakMatch comparison, EGADS CPU performs similarly as X! Tandem, with EGADS 
being more efficient in input pre-processing and X! Tandem being slightly more efficient in 
digestion and scoring (based on the relative changes in runtimes as the search space increases). 
On average, EGADS GPU performed 36.9X faster than X! Tandem and 25.7X faster than 
EGADS CPU, showing that PeakMatch is much more amenable to GPU-acceleration than the 
Xcorr similarity function. 
 
47 
 
Table 3-1 Running time of EGADS compared to Comet and X! Tandem. 
Overall running time in seconds of EGADS in both CPU and GPU mode compared to popular search tools. 
Search engine 
Search time (seconds) 
Tryptic 
20ppm 
Tryptic 
1Da 
Semi-tryptic 
20ppm 
Semi-tryptic  
1Da 
 
Xcorr performance 
Comet 363.0 381.0 582.0 2379.0 
EGADS CPU 11.2 37.2 184.0 889.2 
EGADS GPU 4.9 10.0 30.0 172.6 
     
PeakMatch performance 
X! Tandem 161.3 512.3 1104.1 7606.6 
EGADS CPU 41.7 302.8 1023.7 8517.2 
EGADS GPU 4.3 11.2 34.6 233.1 
     
 
 
Effects of search parameters on GPU-acceleration 
To further investigate the influence of various search parameters on GPU-acceleration, we ran 
EGADS in both CPU and GPU mode across a diverse set of conditions, recording the total time 
taken in individual steps across all digestion-scoring cycles (Table B-2). We first looked at the 
acceleration of the digestion step across the three digestion modes (Figure 3-7).  Average 
speedup for tryptic digestion was 15.1X, semi-tryptic digestion was 13.4X, and non-specific 
digestion resulted in an average speedup of 13.1X.  The trend of reduced performance gains for 
more complex digestions is likely due to the overheads associated with each digestion-scoring 
cycle. As the complexity of the digestion increases, the database must be partitioned into smaller 
chunks so that the intermediate data structures can fit within the same amount of GPU memory. 
This phenomenon is also affected by the precursor mass window.  Average digestion speedup of 
15.0X was observed for runs using a precursor mass window of 20ppm while an average of 
13.1X was observed for runs with a precursor mass window of 1 Da.  The increased precursor 
mass window translates into a larger number of scoring events per digested peptide.  The 
memory required to calculate these additional similarity scores result in fewer peptides processed 
per digestion-scoring cycle, leading to larger number of cycles and reduced acceleration. 
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Figure 3-7 Average GPU speedups as a function of digestion mode or similarity function. 
Speedups are computed relative to the reference EGADS CPU implementation. (a) Average speedup of all digestion steps with 
standard error bars shown. (b) Average speedup for the entire scoring phase and for the similarity computation step only. 
Standard error bars are shown. 
 
We next examined the acceleration of the similarity scoring. The scoring phase is composed of 
three main steps: preparation of scoring blocks, computation of similarity scores, and updating 
the per-spectrum results structure. For the entire scoring phase, we observed average speedups of 
4.7X for Xcorr, 38.3X for PeakMatch, and 67.8X for PeakBackground. Focusing only on 
similarity score computations resulted in speedups of 10.0X for Xcorr, 67.2X for PeakMatch, 
and 125.2X for PeakBackground (Fig 3-7). These trends reflect the differences in scoring 
function complexity with greater speedups for more complex functions where the work to data 
ratio is large. For example, the Xcorr function is calculated as a simple dot product between the 
theoretical spectrum and the pre-processed experimental spectrum. The amount of information 
(the binned experimental spectrum) transferred to the local processor is large compared to 
number of operations performed (sums up the bins where theoretical fragments exist) and 
quickly saturates the memory bandwidth on the GPU, limiting gains. In contrast, the PeakMatch 
and PeakBackground algorithms use peak lists, which are much more compact compared to a 
binned spectrum, and performs many more operations (checking fragment tolerances as the two 
peak lists are merged) in scoring, leading to much large speedups compared to the reference CPU 
implementation. As a result, even though there are great differences in the computational 
complexity across the three scoring functions, their actual runtimes are quite similar after GPU 
acceleration (Figure 3-8). 
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Figure 3-8 Total time used for similarity scoring for different similarity functions. 
Total amount of time spent in the similarity scoring phase for searches using a semi-tryptic digestion of the Refseq protein 
database and a 20 ppm precursor mass tolerance. 
 
In CPU based scoring, the computation of similarity scores accounts for over 90-99% of the 
computation time, depending on complexity of the scoring function (lower for simple functions 
like Xcorr). However, in GPU accelerated scoring only the computation of similarity scores is 
accelerated leading to situations where it takes longer to update the results structure than to 
perform similarity scoring on the GPU (notably when Xcorr is used). Introduction of CPU-GPU 
concurrency where the CPU performs this task while the GPU works on the next digestion-
scoring cycle can eliminate this bottleneck in future work. We also note that the time taken for 
CPU-based digestion is 2.76 times that of GPU-based scoring, indicating that digestion, rather 
than scoring would be the bottleneck if not for the GPU-accelerated digestion implemented in 
EGADS. This is particularly important for high-resolution data as this ratio increases to 3.41 if 
instances with a 1 Da precursor window are excluded. 
 
Impact of GPU memory on EGADS runtime 
As memory plays a large role in effecting the speedup of GPU accelerated searches, we directly 
examined its effect on the overall runtime of a GPU accelerated search at different memory 
limits. This is also important for informing GPU purchasing decisions as the same GPU can be 
sold with differing amounts of on-board memory. We performed tryptic, semi-tryptic, and non-
enzymatic searches of the Refseq protein database using a precursor tolerance of 20ppm (the 
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effects at 1 Da are more pronounced as more memory is required for similarity scoring but is an 
unlikely use case for modern high resolution instruments) and the PeakMatch algorithm (Table 
3-2). For fully tryptic searches, EGADS does not benefit from additional memory as it can 
accommodate the entire database in 1-2 digestion-scoring cycles.  For semi-tryptic search and 
non-enzymatic search, moving from 1024MB to 2560MB decreased the runtimes by 15.7% and 
11.1% respectively. This modest improvement indicates that while EGADS benefits from 
additional GPU memory, its scheme for partitioning the computation allows for effective GPU 
acceleration even on devices with limited on-board memory. 
 
Table 3-2 Running time of EGADS as a function of on-board memory. 
EGADS is operated in GPU mode using the PeakMatch algorithm in each of the three digestion modes. Total search times are 
recorded for different amounts of allocated GPU memory. 
Digestion Mode Search time (seconds) 
1024MB 1536MB 2048MB 2560MB 
 
Tryptic 7.93 7.89 7.89 7.89 
Semi-tryptic 9.76 9.01 8.51 8.23 
Non-enzymatic 200.11 190.21 182.37 177.87 
     
 
 
Application of EGADS to open database searching 
We investigated the application of EGADS for blind modification searching by adapting the 
PeakMatch algorithm to include additional ion-series that accounts for shifted fragment ions and 
running it in open mode (precursor mass tolerance set to 200 Da). For comparison, we performed 
blind modification searching using MODa [41], an established blind modification search tool 
that uses sequence tags. On a single run from the HeLa dataset, MODa took 7333 seconds to 
perform a single-blind modification search.  In contrast, EGADS took 357 seconds using its 
modified PeakMatch scoring kernel, making it 20.5 times faster than MODa in nominating the 
most abundant modifications. The recovered modification profiles were similar, identifying 
common expected mass differences (Figure 3-9).  Interestingly, MODa appears to have a slight 
bias towards smaller mass differences based on the modification profile of decoy sequences 
(which can be assumed to be uniform in nature). 
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Figure 3-9 Modification profiles of HeLa dataset as determined by EGADS open searching and MODa.  
Scaled histograms of PSM counts binned to unit mass differences. Bins 0 (unmodified), 1 (missed assignment of mono-isotopic 
peak), and 16 (oxidation) are hidden. (a) Modification profile comparing EGADS and MODa on forward sequences. (b) 
Modification profile comparing EGADS and MODa on decoy sequences. 
3.3.2 MSFragger implements a novel fragment ion index that enables ultrafast 
database search 
Novel fragment ion index enables ultrafast database search 
MSFragger begins by performing an in silico digestion of the protein database (Figure 3-10). It 
then removes redundant peptides and orders them by their theoretical mass (including any 
modified peptides generated as a result of variable modifications), creating a peptide index. 
Although peptide indexing has been described as a way to accelerate database search [37,94,95], 
this step alone has little impact on spectrum similarity calculations, which is the most time-
consuming step. MSFragger addresses this bottleneck by creating a novel theoretical fragment 
index. This enables highly efficient and simultaneous scoring of an experimental spectrum 
against all candidate peptides (see section 2.2.2, Figure 3-2 and Figure 3-10 b-d). 
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Figure 3-10 Database-search strategies and the MSFragger algorithm.  
Conventional database search involves in silico digestion of a protein database (DB) into candidate peptides from which 
theoretical spectra are sequentially generated and compared against experimental spectra. (b) MSFragger digests a protein 
database and generates a nonredundant set of peptides that are arranged in an index, which is then used to generate a fragment 
index for efficient and simultaneous scoring of an experimental spectrum against all candidate spectra.  (c) Mass binning and 
precursor mass ordering in the fragment index allows rapid retrieval of candidate spectra that match a given experimental 
fragment ion. Scores of candidate peptides corresponding to retrieved spectra are incremented. (d) Processing of experimental 
fragment ions results in identification of all matching fragments between the experimental spectrum and candidate theoretical 
spectra, decomposing spectrum-to-spectra matches to fragment-to-spectra matches. Matched fragments can then be used to 
compute a similarity score. 
 
We first evaluated the performance of the MSFragger algorithm on a deep HEK293 [65] data set 
and compared it to that of commonly used search engines Comet [34] and X! Tandem [36]. The 
scores and error rates of modified peptides are likely to be different from those of unmodified 
peptides, prompting class-specific FDR estimation [96,97]. To account for these differences, we 
adopted an extended mass model when computing peptide probabilities, ensuring mass-shift-
dependent FDR estimation and filtering. We note that in open searches, the term ‘modifications’ 
is used interchangeably with ‘mass shifts’ and includes in-source fragmentation events, missed 
cleavages, and isotope errors. Overall, all search engines performed similarly when run using 
similar search parameters (Table 3-3). In the traditional (narrow-window) search, MSFragger 
and Comet identified 9,795 and 9,757 protein groups (1% protein FDR) and 456,548 and 
461,806 PSMs (1% protein and PSM FDR), respectively. MSFragger also identified similar 
numbers as X! Tandem, when accounting for the innate variable modifications that X! Tandem 
specifies by default. In open search, which represents the primary motivation for the 
development of MSFragger, we observed a dramatic increase in the number of identified PSMs 
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across all search engines, in line with the earlier report using SEQUEST4. For example, 
MSFragger identified 609,897 PSMs using open search, an increase of 33.6% compared to 
narrow-window search, with a minimal loss of 1.4% in the number of protein identifications. 
When performing protein inference using open-search results, we took a conservative approach, 
using only unmodified peptides and peptides with specified variable modifications (Online 
Methods). When all modified peptides were included, the number of protein identifications from 
open searches exceeded that of narrow-window searches (for example, by 4.4% for MSFragger). 
However, additional work is necessary to carefully evaluate the accuracy of the protein inference 
step when using all peptides identified in open search. 
Table 3-3 Identification rates and analysis time for the HEK 293 data set.  
Identification numbers are for the entire 24-run LC-MS/MS data set, filtered at 1% FDR at both protein and PSM levels. Search 
times given are for a single LC-MS/MS run consisting of 41,820 MS/MS spectra analyzed on a quad-core workstation.  
Search engine Time (min) Proteins PSMs Peptides 
Narrow-window search 
SEQUESTa 9.3 9,513 396,736 110,262 
Comet 1.7 9,757 461,806 115,612 
X! Tandemb 1.7 10,182 466,701 119,304 
MSFragger 0.4 9,795 456,548 115,755 
     
Open search (500 Da) 
SEQUESTa 673.0 9,178 510,139 111,205 
Comet 815.4 9,545 584,218 123,679 
X! Tandem 976.0 9,830 638,052 133,318 
MSFragger 5.4 9,656 609,897 126,037 
     
a For time estimation, SEQUEST searches were performed using Proteome Discoverer 2.1 (SEQUEST HT) on a more powerful 
eight-core workstation. Narrow-window searches were done with a 100-p.p.m. precursor mass window, except for SEQUEST (5 
p.p.m.). SEQUEST identification rates were taken from ref. [65].  
b X! Tandem searches include several variable modifications that cannot be turned off. 
 
Open searches using conventional database search tools are slow, given the vastly expanded 
search space. Comet and X! Tandem took 13.6 and 16.3 h, respectively, to analyze a single LC-
MS/MS run using a quad-core workstation. In stark contrast, MSFragger took only 5.4 min, 
making it >150 times faster than these commonly used tools. We also compared MSFragger to 
tools that employ peptide indexing, such as Tide [89] and SEQUEST HT (Table B-1). Tide, 
which allows 100-Da precursor windows only and does not take advantage of multiple processor 
cores, took 176.7 min (compared to 9.8 min with MSFragger when subjected to the same 
constraints). SEQUEST HT (Proteome Discoverer 2.1) took more than 11 h on a more powerful 
octa-core workstation. The speed and scalability (Figure 3-3) of MSFragger allowed open 
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searching of the entire HEK293 data set (24 LC-MS/MS runs) in less than 30 min on a single 
powerful workstation, compared to the days or even weeks that would be required to search these 
data using existing tools on the same machine. 
 
 
Figure 3-11 Open searching identifies similar modifications as MODa. 
MODa, run in single blind mode, generates a similar modification profile as that of an open search with differences that are likely 
due to the characteristics of the modification.  Open searches (run in fully tryptic mode in both comparisons) are more likely to 
recover mass shifted peptides that have little discernible alterations in their tandem mass spectra (such as the modification near 
302 Da) as it does not attempt to localize the modified mass.  MODa is likely more effective for modifications that are more 
commonly found near the C-terminus (and disrupts the y-ions used in open search identification).  MODa running in semi-tryptic 
mode (the mode of operation as recommended by its authors) recovers a greater number of PSMs at the expense of additional run 
time. 
 
We also sought to compare MSFragger to algorithms specifically designed for comprehensive 
PTM analysis. MODa[41] has been established as an effective tool for blind PTM search. Using 
comparable settings, both tools produced very similar PTM profiles (Figure 3-11), but 
MSFragger identified a larger number of PSMs than MODa, at an FDR of 1%: 622,857 
(MSFragger, tryptic search) versus 522,812 (MODa, semi-tryptic search) and 439,216 (MODa, 
tryptic search). The difference between MODa and MSFragger results can be explained, in part, 
by the fact that MODa’s algorithm localizes the mass shift to a particular amino acid, whereas 
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open searching identifies only the peptide sequence and the mass shift (which may be the result 
of multiple modifications). Considering the computational time, MSFragger was notably faster 
(5.4 min; 24.5 min when restricted to a single core) than MODa, which took 204.7 min (semi-
tryptic search) and 150 min (tryptic search) for a single LC-MS/MS run on a quad-core 
workstation (Table B-1). 
3.4 Discussion 
In this chapter, we presented two database search tools that are both considerably faster than any 
existing tools. EGADS allows narrow window searches to be rapidly performed on large search 
spaces (such as semi-tryptic or non-enzymatic digestions involving custom databases predicted 
from sequencing data) as the GPU-accelerated digestion component is much faster than the 
CPU-based indexing performed by MSFragger while not performing a large number of similarity 
scores. However, the requirement of specialized hardware makes it inaccessible to many users 
and prohibits deployment on inexpensive cloud computing resources. The ability of MSFragger 
to run on conventional computers makes it much more accessible and scalable. Its algorithmic 
strength in similarity calculations makes it ideal for open searches where a large number of 
similarity comparisons are calculated. However, for narrow window searches, much of the 
fragment index can be left untouched when they represent the theoretical fragments of digested 
peptides that have no experimental spectra within the precursor mass tolerance. This inefficiency 
can be ameliorated to a certain extent by running MSFragger in batch mode, where multiple LC-
MS/MS runs are processed sequentially, reusing the generated fragment index and increasing the 
coverage of the m/z range by experimental precursors. For users without access to GPUs, 
MSFragger in narrow window mode still enables much faster searches than conventional search 
tools, especially in batch mode. However, for labs equipped with the capability to perform both 
types of searches, the two tools or approaches are complementary, with EGADS more suitable 
for narrow window searches and MSFragger for open searches. It is also worthy to note that 
EGADS implements multiple scoring functions, potentially enabling multiple GPU accelerated 
searches to be performed using different scoring functions to reduce the number of false 
positives that are ambiguous identifications. 
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The indexing algorithm presented in MSFragger has the potential to be used in a number of 
different mass spectrometry applications where comparing spectra is a computational bottleneck. 
This includes spectra clustering, testing new hypotheses on indexed experimental spectra, or 
identifying spliced peptides. The algorithm can also be adapted to consider shifted fragment ions 
to further empower the open search concept by building different fragment indices based on 
fragment charge. Finally, as the approaches are orthogonal, a GPU implementation of 
MSFragger is theoretically possible, allowing such an implementation to be thousands of times 
faster than the conventional database search tools today that do not employ either innovation 
3.5 Data availability 
Raw mass spectrometry files are available from public repositories as described. The processed 
data files supporting the findings of this study are available upon request.  The EGADS database 
search tool is available upon request. MSFragger can be obtained from 
www.nesvilab.org/software. A software manual for running MSFragger can be found in 
Appendix D. 
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CHAPTER IV 
COMPREHENSIVE PROFILING OF MODIFIED PEPTIDES IN 
SHOTGUN PROTEOMICS USING THE                                         
OPEN SEARCH STRATEGY  
Contents of this chapter have been published in Nature Methods [62] 
4.1 Introduction 
Post-translational modifications (PTMs) regulate cellular functions in ways that cannot be 
studied through deep genomic or transcriptomics sequencing. A wide range of PTMs including 
phosphorylation, ubiquitination, glycosylation, and acetylation has been characterized and 
localized to tens of thousands sites in the human proteome [98]. The most common and prevalent 
PTM studied is phosphorylation likely due to their function in signaling and involvement in 
cancer processes [99]. In these studies, the PTM of interest is often chemically enriched prior to 
analysis by mass spectrometry. Hence, it was of surprise and excitement when it was reported 
that an additional 30% PSMs were identified to be modified peptides by the open search strategy 
in an non-enriched HEK 293 proteome, indicating that there is a vast assortment of chemical and 
post-translational modifications that can be studied without enrichment in datasets already 
present in public repositories [100] representing diverse tissues and conditions. Furthermore, the 
open search strategy is known to recover only 50% of modified peptides, suggesting a potential 
increase in the identification rates by another 30%.  The large number of modified peptides 
collected in non-enriched samples might be due to recent increases in instrument speed, allowing 
less abundant modified peptide forms to be effectively sampled in data-dependent acquisition. 
These modified peptides have long eluded identification in tandem mass spectrometry even 
though their spectra are collected due to the computational burdens of identifying blind 
modifications, making them part of the dark matter of shotgun proteomics [101]. The open 
58 
 
search strategy provides a simple and direct opportunity to illuminate this dark matter and allow 
us to comprehensively study the full complement of chemical and post-translational 
modifications in proteomics. 
 
The open search strategy is not without limitations. Open searching can be computationally 
infeasible for large datasets without the use of the more efficient algorithms presented in Chapter 
Three. Aside from the computational costs, it does not recover all peptides all unmodified 
peptides, recovers only 50% of modified peptides (even for the most common modifications), 
and has difficulties identifying peptides with modifications near the peptide C-terminus (due to 
the unaccounted for shifted y-ions). Hence, we attempted to address these concerns and refine 
the open search strategy through MSFragger. In addition, we wanted to examine the diversity 
and abundances of modifications across experiments to understand if their impact on false 
positives is uniform across different experimental conditions or if the most common 
modifications are consistent enough to be targeted through simple variable modification 
searches. For these purposes, we performed large scale modification profiling of various shotgun 
proteomics experiments and also examined the presence of modified peptides in several 
proteomics applications. 
4.2 Materials and methods 
Datasets and Data Preparation 
Six public datasets, all analyzed using the Thermo Scientific Q Exactive mass spectrometer was 
obtained and conversion of vendor .raw files to mzML was performed as previously described. 
Three of the six was used for the large-scale profiling studies: a HEK 293 dataset [65] 
(PXD001468, 1.12 million MS/MS spectra), a HeLa dataset [99] (HeLa proteome profiles from 
PXD000612, 2.8 million MS/MS spectra), and a triple-negative breast cancer (TNBC) dataset 
[66] (PRDB004167, 19.6 million MS/MS spectra). A clinical breast cancer dataset [102] 
(PXD000815, 34.3 million MS/MS spectra) was used for the SILAC analysis. A large scale 
study involving 5,188 LC-MS/MS runs [103] (raw data obtained from authors, 64.7 million 
MS/MS spectra) was used for the AP-MS analysis. Finally, a human RNA binding protein study 
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[104] (human RBP runs from PXD000513, 8834 MS/MS spectra) was used to demonstrate the 
utility of MSFragger in detecting RNA-crosslinked peptides. 
 
Boosting unmodified peptides 
MSFragger implements an unmodified peptide boosting feature. When invoked, PSMs that have 
an absolute value of the mass shift dM (defined as the difference between the theoretical and 
observed precursor peptide mass) less than the true precursor tolerance threshold specified by the 
search parameters ‘precursor_true_tolerance’ / ‘precursor_true_units’ are placed into a different 
scoring heap that only contains such unmodified peptides. After the calculation of expectations 
for all PSMs in both the regular and unmodified scoring heap, a ranking expectation is generated 
for all PSMs. For entries in the regular scoring heap, containing both modified and unmodified 
PSMs, the ranking expectation is the same as the computed expectation. The ranking expectation 
for entries in the unmodified peptides heap are modified based on the specified search 
parameters (multiplied by the specified expectation boost or an arbitrary small value for those 
that pass the ‘zero_bin_accept_expect’ expectation) and recorded as the ranking expectation. All 
PSMs are then merged and ordered by their ranking expectations prior to results reporting. It is 
important to note that the original expectations are reported rather than the ranking expectation. 
 
Complementary ions for the recovery of C-terminal modifications 
The addition of complementary ions follows the basic spectra pre-processing described 
previously [105,106]. The top N observed fragment ions, as specified by the 
‘add_topN_complementary’ ions parameter are selected and are assumed to be either a singly 
charged y-ion for all spectra and a doubly charged y-ions for spectra with an identified charge 
state of 3+ or higher. The m/z of the complementary singly charged b-ion is then calculated from 
the calculated neutral mass of the assumed y-ion and the observed precursor mass. A 
complementary ion with this m/z and intensity equal to the y-ion from which it was derived is 
then inserted into the spectrum. Note that complementary ions are generated for both the singly 
charged and the doubly charged assumption of the observed fragment ion so that N 
complementary ions are inserted for spectra with charge state 2+ and 2N complementary ions are 
inserted for spectra with charge state 3+ or higher.  These modified experimental spectra are then 
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subjected to open database searching.  As the original experimental fragment ion (from which 
the complementary ions are generated) is retained in the spectrum, it is possible that a single 
experimental observation can be incorrectly interpreted as multiple fragmentation events.  Future 
work involving the addition of complementary ions to the theoretical spectrum instead will 
eliminate this problem and improve localization of modifications. 
 
MS1-based precursor mass correction and identification based calibration 
Instrument recorded precursor mass values for MS/MS spectra can be inaccurate while repeated 
observations of a precursor in survey (MS1) scans can be highly precise. A supplementary tool 
was developed as part of the MSFragger pipeline that, for each MS/MS event, takes the recorded 
m/z and retention time, examines the corresponding space in MS1 scans, and extracts the nearest 
peak feature by tracing the mass in retention time.  The m/z is then calculated as a weighted 
average (by intensity) of all peaks in the trace. The precursor m/z for each MS/MS event is then 
updated with this value. For certain MS/MS events in which it was not possible to reconstruct the 
associated peak feature, no changes to the recorded m/z are made. Following precursor mass 
correction, identification-based mass recalibration of the MS/MS run is performed. In order to 
compare modification profiles that are resolved at sub-ppm levels across disparate experiments 
and labs, this calibration step is critical as slight deviations can cause broadening of features in 
the profile and loss of power in recovering modifications. To perform this calibration, 
unmodified peptide identifications (filtered at 1% PSM level FDR using the PeptideProphet 
probability) with observed mass difference dM less than 20ppm are selected. As instrument bias 
may drift over time and varies across m/z, a two-dimensional calibration grid is constructed 
using a retention time width of 5 minutes and an m/z width of 200 m/z. For each unmodified 
peptide, the corresponding cell in the grid is found. A weighted ppm bias, based on the proximity 
to each point, is added to each of the four points corresponding to that cell. The weighted 
averages on the calibration grid are then used to adjust the precursor m/z for all observed MS/MS 
events in the run. The corrected and calibrated m/z values are then written to a calibration file 
that is incorporated in downstream analysis. 
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Figure 4-1 MS-1based precursor mass correction and identification based calibration.  
(a) Visualization of a monoisotopic peptide ion peak using Batmass represented as a series of different observed m/z along 
retention time (vertical axis).   (b) Calibration adjustment factors applied to each PSM plotted by their observed m/z and retention 
time. 
Large scale profiling of chemical modification 
Large scale profiling of chemical modifications was performed using the sequence database 
created from the human sequences of UniprotKB (Download date: 2015-10-09) appended with 
reversed protein sequences as decoys and common contaminants (cRAP proteins sequences from 
gpmDB and contaminants from MaxQuant). A precursor mass tolerance of 500 Da was used 
with fragment tolerance of 20 ppm.  Isotopic error correction was disabled and common variable 
modifications of methionine oxidation and N-terminal acetylation were enabled. 
Carbamidomethylation was specified as a static modification.  PSMs and peptides that contain 
modifications that were specified in our search parameters were not considered to have a mass 
shift for the tabulation of mass shifts.  Fully tryptic digestion was specified allowing up to 1 
missed cleavage.  Complementary ions and boosting features were disabled and other 
MSFragger options were left as default. 
 
MSFragger search results from each LC-MS/MS run were subjected to peptide validation as 
described above. Peptide probability was determined by the highest supporting PSM probability. 
Results for each experiment were aggregated and filtered at 1% peptide FDR. PSMs were 
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separately filtered at 1% PSM FDR and only PSMs that passed both the 1% PSM FDR and 1% 
peptide FDR were retained for downstream analysis. 
 
Modeling of observed modification profiles and detection of modification peaks 
Normalized density profiles for each experiment were generated for comparison across different 
experiments. Corrected mass differences, with random noise on the order of +/- 5 μDa added to 
break ties, were binned using 0.0002 Da bins to form an initial counts histogram. These counts 
were then distributed to adjacent bins using the weights 0.23 (bin to left), 0.49 (same bin), 0.23 
(bin to right) to smooth the histogram and improve the monotonicity of peak shapes. These 
histograms were then normalized by dividing each bin by the total number of spectra (in 
millions) acquired in the respective experiments.  Averaging the counts in each bin generated an 
average profile of the three experiments. Mixture modeling of the average profile failed to 
precisely capture known modifications. Examination of the profile revealed peaks of varying 
broadness and further examination revealed the peak shape to be a complex function of the 
charge state and m/z of the underlying PSMs.  Instead, a prominence based peak detection 
method was used that found features on the histogram by requiring that the peak prominence was 
at least 0.3 times that of the peak height.  As known modifications were observed to have a peak 
width of approximately 0.004 Da (given current instrument accuracies and the 
correction/calibration method applied as described above), these features were ordered by the 
rise in density compared to the 0.003 Da flanking regions.  It should be noted that some of the 
detected features (mass bins) could be artifacts of the peak picking algorithm, or may correspond 
to various combinations of multiple modifications. 
 
Mass shift annotation using Unimod 
The Unimod repository was downloaded (on 2016-04-22) in XML format and was parsed to 
extract modification names and mass shifts.  Mass shifts associated with the addition or deletions 
of the twenty amino acids were appended to this list.  Multiples of the mass difference between 
carbon-13 and carbon-12 were added as ‘First isotopic peak’ and ‘Second isotopic peak’ to 
account for isotopic peak picking errors.  Entries that represent a single mass shift in this list 
were concatenated into a single entry so that a single text identifier represented each mass shift.  
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Annotation of the list of mass shifts proceeded in decreasing order of abundance.  For each mass 
shift, the mass is queried against the described database of annotations with a mass tolerance of 
0.002 Da.  If a match is found, the mass shift is annotated with the entry from the database.  If 
the mass shift cannot be matched to a single entry in the database, we attempt to compose 
multiple (up to 3) previously observed (in the order of annotation) mass shifts to account for 
compound modifications.  If the mass shift remains unexplained, we add it to our list of 
annotations as a new un-annotated mass shift. 
 
Localization of detected mass differences  
For each PSM, including unmodified peptides, the observed mass difference is evaluated to see if 
it can be attributable to a modification of a specific site (position in the peptide).  For each 
MS/MS run, the list of identified spectra (which includes the spectrum ID, peptide sequence, list 
of variably modified amino acids, and observed mass difference) is obtained from the 
MSFragger analysis pipeline, and the corresponding MS/MS spectra are extracted from the 
original mass spectrometry data file. The number of matched fragment ions is then re-computed 
using the same hyperscore function as originally done in MSFragger. The observed mass 
difference is iteratively placed on each amino acid, and for each position the spectrum similarity 
is computed to derive the number of matching fragment ions, and then the hyperscore.  A PSM is 
called localizable if there is at least one position that generates a higher number of matched 
fragments than the rest. As there may be insufficient fragments to support an unambiguous 
localization in the peptide sequence, all positions that share the highest hyperscore are marked as 
a possible localization site.  A PSM is called to be localized to the N-terminal if the localized 
positions form an uninterrupted stretch of amino acids from the N-terminal. 
 
The localization results are then aggregated for each identified mass bin, and their localization 
characteristics examined. For each bin, the overall localization rate (the percentage of PSMs 
within that bin that are localizable), the N-terminal localization rate (the percentage of PSMs 
within that bin that are localizable and the localization is N-terminal), and the amino acid 
enrichment are computed. The amino acid enrichment is determined by first computing the 
amino acid composition of all peptides within the mass bin. Then, the number of localization 
sites attributable to each amino acid is summed across all localizable PSMs (for a PSM with 
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multiple localization sites, each site gains a weight equal to 1 / number of localized sites).  The 
total localization count for each amino acid is then normalized to form the localization rate. 
Amino acid enrichment is then determined by the ratio of localization rate to composition rate.  It 
should be noted that while this metric is informative in many cases, it may be misleading in bins 
containing few PSMs or bins that are dominated by several abundant peptides that skews the 
counts and normalization factors. 
 
Spectral similarity scores for modifications 
For each modified PSM, we identify corresponding PSMs of the same charge state that identifies 
the same peptide but with a mass difference of less than 0.001 Da (indicating an unmodified 
peptide).  We compute the average cosine similarity between the spectrum of the modified PSM 
and spectra corresponding to the unmodified peptide (if there are more than 50 such spectra, 50 
are chosen at random).  We then normalize for variations within unmodified spectra by dividing 
the average cosine similarity within the set of unmodified spectra to obtain a similarity score for 
the modified PSM.  For each modification mass, its similarity score is determined by averaging 
the similarity scores calculated for each modified PSM within its mass tolerance. 
 
Analysis of SILAC datasets 
The breast cancer SILAC dataset was analyzed using the same search settings as the large-scale 
modification profiling described above with the exception that two variable modifications were 
added for the heavy labeled residues: 8.0142 Da at lysine and 10.00827 Da at arginine. Precursor 
mass correction/calibration and peptide validation were performed on each file and the 
aggregated files from the experiment were subjected to a 1% peptide and PSM FDR filter (each 
retained PSM passed 1% PSM FDR and matched a peptide that passed 1% peptide FDR).  Each 
PSM in the resultant list was then examined for the presence of a heavy labeled residue (as 
determined by identification with a heavy labeled variable modification). Unlabeled PSMs were 
considered to have originated from the patient samples while labeled PSMs were considered to 
have originated from the super-SILAC mix. 
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Analysis of AP-MS dataset 
Open search parameters for the AP-MS dataset were also similar to the settings used for large-
scale modification profiling with one exception. As iodoacetamide treatment of samples was not 
used, no static modification was specified for cysteine. Each of the 5,188 runs was subjected to 
peptide validation and mass correction individually. FDR filtering was performed for each run 
individually, filtering the data at 1% FDR (at both peptide and PSM levels). Narrow window 
searches were performed using the same parameters with the exception of a 20 ppm precursor 
tolerance window and isotope selection errors of 0/1/2 was enabled. 
 
For each LC-MS/MS run, all PSMs that were matched to a UniProt accession associated with the 
bait protein were considered to have originated from the bait protein (including any shared 
peptides). The number of unique sequences was determined by examining the set of unique 
peptides represented by the PSMs. Total counts for a particular bait protein across the replicates 
were determined by summing bait PSMs across the two replicates and determining the number of 
unique peptide sequences.  Average fold change between narrow window and open searches was 
determined by linear regression in R. 
 
Analysis of RNA-protein crosslink dataset 
Open searching for the crosslinking dataset was performed similar to the large-scale modification 
profiling searches. The precursor mass window was enlarged to +/- 1000 Da to accommodate 
heavier crosslinked fragments. Carbamidomethylation was not specified as a fixed modification 
on cysteine. Comparison of results obtained by RNPxl and MSFragger was performed using the 
peptide sequence and mass difference. Identifications from RNPxl were translated into a peptide 
sequence and a total RNA-peptide mass. Identification from MSFragger was considered to be a 
match if it shared the same peptide sequence and had a total mass that differed from the RNPxl-
based identification by no more than 0.05 Da. 
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4.3 Results 
4.3.1 Refinement of the open search strategy using MSFragger 
The development of MSFragger algorithm not only makes open searching practical, but also 
presents an opportunity to further investigate and refine this computational strategy. It is often 
assumed that the number of identified unique peptide sequences would be greatly reduced in 
open search compared to narrow window search due to the vastly expanded search space. 
However, our results using multiple search engines (Table 3-3) demonstrate that this is generally 
not the case. At the same time, it is true that not all unmodified, tryptic peptides found in narrow 
window search are found in open search. To see if those peptides can also be recovered, we 
implemented a boosting feature within MSFragger that preferentially ranks unmodified peptides 
over modified peptides when performing open search (see section 4.2). However, such a 
strategy, while implemented as an option in MSFragger, has not been found to significantly 
improve the results (Figure 4-2).  
 
  
Figure 4-2 Preferential boosting of unmodified peptides fails to rescue missing peptides. 
Boosting recovers a greater percentage of the peptides found in narrow window search prior to FDR filtering.  Note that not all 
peptides identified in narrow window search are recovered in open search with the boosting option enabled due to the presence of 
a default peptide probability filter of 0.05 in PeptideProphet (disabling this filter using the –p0 option results in near 100% 
recovery).  However, after controlling for FDR, boosting does not improve the peptide overlap between open and narrow window 
search. 
 
In open searching, there is often a reduction in sensitivity for modified peptides containing 
common modifications that are specified as variable in narrow window searching (as open 
searching does not account for modified fragment ions). In order to address this issue, the speed 
of MSFragger allows us to specify variable modifications in conjunction with open searching. 
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We selected peptides identified with a single oxidized methionine in narrow window search and 
examined the proportion of such peptides observed in open search (explicitly as an oxidized 
methionine containing peptide or with a mass difference of +16 Da).  In an open search without 
variable modifications, 45.4% of the peptides with oxidized methionine could be recovered in 
comparison to 87.5% for all peptides (Figure 4-3).  Specifying oxidized methionine as a variable 
modification in our open search boosted the percentage of recovered oxidized methionine 
peptides to 88.8%, which is close to the 90.3% recovered for all peptides. 
 
 
Figure 4-3 Decreased sensitivity for common modifications in open searching can be overcome by specifying variable 
modifications. 
Standard open searches tend to identify far fewer peptides modified with common modifications than narrow window searching 
specifying those modifications as variable modifications.  This is due to decreased sensitivity when the shifted ions are no longer 
matched in open search.  For the most abundant chemical modifications, this can result in a significant decrease in overall counts.  
The speed of MSFragger allows variable modifications to be specified in conjunction with open searching.  Examining peptides 
with oxidized methionine reveals that standard open search recovers only 45.37% of the peptides originally identified with 
oxidized methionine in narrow window searching (with variably oxidized methionine).  Specifying oxidized methionine as a 
variable modification in open search brings that percentage to 88.81%, close to the overall overlap in peptide identifications 
between narrow window and open searches. 
 
One apparent weakness of the open search strategy, compared to other strategies for blind PTM 
analysis such as spectrum alignment, is that it only considers unmodified fragment ions in 
scoring. Thus, C-terminal modifications are more difficult to detect using open searching as most 
y-ions, which are the most abundant and commonly observed in CID/HCD fragmentation, are 
shifted by the modification mass. Under the assumption that the most intense fragment ions are 
shifted y-ions, generating complementary ions [76,105] using the experimental precursor mass 
would yield unmodified b-ions that can be detected in open searches. We tested this hypothesis 
by inserting 10, 20, and 30 complementary ions in the experimental spectrum as a preprocessing 
step prior to searching and benchmarked this process using peptides with a single oxidized 
methionine. The addition of complementary ions slightly decreased the identification rates of 
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peptides with modifications near the peptide N-terminus but greatly increased identification rates 
of peptides with modifications near the C-terminus (Figure 4-4).  For peptides with an oxidized 
methionine just upstream of the tryptic cleavage site, the number of identified peptides increased 
by 48% when 20 complementary ions were added.  As the number of complementary ion 
increased, the overall identification rates decreased due to the addition of noise in the spectrum.  
In our experience, the insertion of 20 complementary ions is optimal for detection of C-terminal 
modifications using the open search strategy. Because the overall improvement in the number of 
identifications (taking into consideration the unmodified peptides as well) when using the 
complementary ions was not significant, we elected not to use this option for the majority of 
analyses presented in this work. A more efficient strategy to account for shifted fragments would 
be to add complementary ions to theoretical spectra via extension of the fragment ion indexing 
scheme, which we plan will pursue in future work.  
 
 
Figure 4-4 Complementary ions aid recovery of peptides with modifications near peptide C-terminus. 
(a) High intensity fragment ions are selected from the experimental spectrum and are assumed to be modified y-ions.  
Complementary ions based on the experimental precursor mass are inserted to form a modified spectrum that is subjected to open 
searching. (b) Evaluation of complementary ions using peptides containing a single oxidized methionine.  10, 20, and 30 
complementary ions were inserted into each experimental spectrum and the counts of identified peptides were ordered by the 
distance of their oxidation site to the N or C-terminus.  The addition of complementary ions decreased the number of 
identifications for peptides with oxidation near the N-terminus but greatly increased identification rates for peptides with 
oxidation near the C-terminus.  For peptides with an oxidized methionine upstream of the tryptic cleavage site, the number of 
identified peptides increased by 48% when 20 complementary ions were added.  The addition of more than 20 complementary 
ions was not found to be beneficial. 
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The problem of co-isolating multiple co-eluting peptides and the resulting chimera MS/MS 
spectra is well established [20,107] and manifests itself in unique ways in open searches. When a 
co-fragmented peptide is identified with a higher score, an artefactual (not attributed to any 
modification) mass shift is produced that can either be small (within several Daltons) or large 
(hundreds of Daltons) depending on whether the co-fragmented peptide ions are of the same or 
different charge state, respectively. Such cases can be identified using linked MS1 and MS/MS 
spectral viewers (Figure 4-5 a,c), and further evaluated using tools such as BatMass [91] (Figure 
4-5 b,d). While the number of such cases is small, in future work chimeric spectra can be dealt 
with more accurately in open searches via MS1 feature detection of co-isolated peptides [37] 
within MSFragger or using external tools [108].  
4.3.2 Large-scale profiling of unlabeled shotgun proteomics experiments 
MSFragger’s ultrafast performance enables comprehensive profiling of chemical and biological 
modifications across multiple large-scale proteomics datasets. To demonstrate this, we probed 
three large proteome-wide studies using open searches and compared their modification profiles.  
In addition to the HEK 293 dataset used to benchmark MSFragger, a HeLa proteome dataset 
[99], along with a dataset consisting of various triple-negative breast cancer (TNBC) cell lines 
and tissues [66] were used (see section 4.2). We additionally implemented a supplementary tool 
for MS1-based correction of precursor masses followed by identification-based mass 
recalibration. This allowed us to achieve sub-ppm mass accuracy and improved our ability to 
delineate modifications having close masses across disparate experiments and labs (Figure 4-6). 
The list of 500 most abundance mass shifts (excluding modifications specified as variable 
modifications in the search) is shown in Table C-2. We confirmed that in all datasets FDR 
estimates for modified peptides were well controlled and not inflated compared to unmodified 
peptides. For example, in HEK 293 dataset, peptide-level FDR was 0.18%, 0.11%, and 0.11% 
for peptides with top 500 most abundant mass shifts, top 100 mass most abundant shifts, and for 
unmodified peptides, respectively (FDRs computed separately for 500 most abundant mass shifts 
are shown in Table C-2).  
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Figure 4-5 Co-isolation of co-eluting precursors can result in mass differences that are not due to chemical modifications.  
(a) A MS/MS event was triggered at m/z 685.84 (green arrow) resulting in the identification of the peptide 
LGPALATGNVVVMK with a mass difference of 0.878.  The parent survey scan reveals a co-eluting precursor with m/z 685.40 
(cyan arrow).  The difference in m/z at charge 2+ matches the observed mass difference suggesting that the co-eluting precursor 
is identified instead of the target precursor in this chimeric spectrum. (b) BatMass visualization of the MS/MS event described in 
(a) with MS/MS isolations marked by the purple line segments. The cyan arrow indicates the monoisotopic peak of the target 
precursor while the red arrow indicates the monoisotopic peak of the identified precursor. (c) The peptide RESVELALK was 
identified with a mass difference of -349.185 at m/z 348.21 (green arrow).  Parent survey scan reveals a co-eluting precursor with 
m/z 348.87 (cyan arrow).  While the target precursor ion is of charge 2+, the co-eluting precursor is of charge 3+, which 
transforms this 0.66 difference in m/z between these co-eluting precursors into the observed mass difference of -349.185.  (d) 
Similar BatMass visualization of the MS/MS event described in (c).  Note how the isolation window of the charge 2+ target 
precursor (cyan) crosses the monoisotopic peak of the charge 3+ co-eluting precursor (red). 
 
We first interrogated several common chemical modifications (Figure 4-7a). Although the 
localization profiles were largely concordant (Figure C-1), their normalized abundances 
(modification rates) across the datasets were quite dissimilar. For example, the rate of 
phosphorylation in the HeLa dataset was over 14 times than that in the TNBC dataset. 
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Furthermore, some of these modifications were found on amino acids that are generally not 
considered in traditional workflows, such as tryptophan oxidation.  
 
 
Figure 4-6 MS1-based correction of precursor masses and identification-based calibration helps delineate modifications in 
close mass proximity.  
Identified number of PSMs with mass differences in the range of 0.98 Da to 1.01 Da from a single HEK293 LC-MS/MS run.  
Expected mass differences in this range are due to deamidation (with a delta mass of 0.984 Da) and C12/C13 error (with a delta 
mass of 1.003 Da). (a) Prior to correction a broad peak with no coherent shape is observed with a center around 1.005 Da.  
Knowledge of expected mass differences may lead to the calling of a peak near 0.986 Da. (b) Two cleanly resolved peaks are 
observed after mass correction.  Expected peaks corresponding to deamidation and C12/C13 error are resolved with mean mass 
accurate to 1/1000 Da.  The ability to determine such peaks from a single LC-MS/MS run demonstrates the accuracy of modern 
instruments and the power of our mass correction procedure. 
 
We observed many highly abundant modifications that lacked annotations in Unimod and were 
unique (or of much greater abundance) to a particular dataset (Table C-2). To help decipher these 
unannotated (based on Unimod) modifications, we performed site localization analyses (section 
4.2; Table C-1). For example, the HeLa dataset contained many peptides (over 23,000 PSMs) 
with a modification mass of 52.913 Da that were often localized to aspartic acid or glutamic acid, 
characteristic of metal ion adducts.  This is likely to be iron displacing three protons (Unimod 
annotates ‘Replacement of 2 protons by iron’ modification only). We observed that many 
unannotated (in Unimod) mass shifts occurred on cysteines (Figure 4-7b). While some can be 
explained (e.g. 151.996 corresponding to carbamidomethylated DTT modification of cysteine), 
deducing the identities of unannotated mass shifts was outside the scope of this work. 
 
For some modifications, we were unable to localize the mass shift on the peptide (Figure 4-7c). 
This suggests that there are few fragments that support the modification mass or that the detected 
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modification mass is the result of a multiple modifications found on the same peptide. To 
investigate such cases, for each modification mass we computed a spectral similarity score 
between peptides containing that modification and their corresponding unmodified forms (see 
section 4.2; Figure 4-8). Most modifications possessed a similarity score between 0.4 and 0.6, 
including known modifications such as phosphorylation. However, we observed a large number 
of modifications (e.g. 3417 PSMs with mass shift 301.986 Da in HEK 293 dataset, 3068 PSMs 
with mass shift 284.126 Da in HeLa dataset) with similarity scores close to 1, indicating that 
spectra for many of the peptides with these modifications were largely unchanged from that of 
the unmodified peptide (Figure C-2). The lack of differences in the spectra and relative 
uniqueness to a particular dataset (Table C-2) suggests labile modifications that are specific to 
sample preparation protocol.  
 
 
Figure 4-7 Modification profiles in large-scale HeLa, HEK293, and TNBC shotgun proteomics experiments. 
(a) Examples of common modifications showing differences in modification rates. (b) Examples of abundant modifications that 
were unique to particular experiments. (c) Examples of abundant mass features where the mass difference could not be 
effectively localized. 
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Figure 4-8 Open searching detects modified peptides containing labile modifications.  
Spectral	similarity	scores	for	each	mass	bin	were	computed	to	capture	the	spectral	similarity	between	a	modified	peptide	and	its	
unmodified	counterpart.	Spectra	acquired	from	a	13C	(12C/13C)	error	are	highly	similar	to	those	acquired	from	the	unmodified	form	serving	
as	a	natural	threshold	(dotted	line)	of	similarity	significance	between	modifications	with	a	higher	similarity	score	(red)	and	those	with	a	
lower	score	(blue).	Mass	differences	of	interest	are	labeled	and	shown	in	yellow.	Inset,	quantile	plot	of	similarity	scores	across	
modifications.	
4.3.3 Modified peptides in various proteomics applications 
MSFragger enables a wide range of analyses beyond interrogation of unlabeled proteomes. First, 
we are able to perform open searches using spectra from labeling-based experiments (e.g. 
SILAC, TMT, or iTRAQ) by specifying the labeled amino acids as a variable modification, thus 
allowing quantitative comparison of the modification states of proteins en masse. To test this, we 
examined a breast cancer dataset consisting of 442 LC-MS/MS runs representing 88 formalin-
fixed paraffin-embedded (FFPE) patient samples that were analyzed together with a heavy 
labeled super-SILAC mix [102]. The open search (with variable SILAC modifications) of over 
34 million MS/MS spectra from this dataset took less than three days. Examination of the 
modification profiles revealed a wide range of abundant modifications in these samples, as well 
as uncovered differences in modification abundances between the breast cancer samples and the 
super-SILAC mix, including a 30.011 Da mass shift that likely represents a methylol adduct 
which is characteristic of FFPE proteomes [109] (Figure 4-9a).  
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Figure 4-9 Application of MSFragger to diverse proteomics experiments.  
(a) Comparison of a panel of breast tissue samples and a heavy-labeled super-SILAC mix, where SILAC-labeled amino acids 
were specified as variable modifications in conjunction with open searching. (b) Bait PSM counts identified in narrow-window 
and open searches in an AP–MS data set. (c) Open searching of an RNA–protein cross-linking data set. Prominent mass 
differences corresponding to RNA fragments are labeled. Inset, length of cross-linked peptides recovered by MSFragger. 
 
Next, we applied MSFragger to a large-scale protein interaction study using an affinity 
purification mass spectrometry (AP-MS) experimental workflow that consisted of 2,594 baits 
analyzed in technical duplicates [103]. We reasoned that lowered sample complexity in AP-MS 
experiments provides an opportunity to examine in-depth the modification state of enriched 
proteins, most notably the proteins used as baits. We performed both narrow window searches 
and open searches on over 64.6 million MS/MS spectra across 5,188 LC-MS/MS runs. Open 
search increased the total number of PSMs by 32%, similar to the increases observed for data 
from whole cell lysates. For the bait proteins, however, the number of identified PSMs increased, 
on average, by almost 300% (Figure 4-9b).  
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For some bait proteins the increase in the number of identified peptide ions and total PSMs was 
astonishing. For example, the mitochondrial persulfide dioxygenase protein ETHE1 - a key 
member of the sulfur oxidation pathway that is itself involved in reactive oxidation of cysteine 
residues [110] - was identified by 48 and 2474 peptide ions in narrow window and open search, 
respectively. A large fraction of this increase for was attributed to cysteine modifications. When 
we subjected the top 100 bait proteins having the largest increase in the number of identified 
peptide ions to functional enrichment analysis using DAVID [111], the top enriched GO: 
Biological Process category (p-value 0.00007) was ‘small molecule metabolic process’ 
containing 23 proteins from the selected list, including ETHE1 (Table 4-1). Proteins in this 
category are involved in catalyzing modification processes and small molecule adducts, which 
may be linked to significantly higher number of modifications observed on these proteins 
themselves. These results suggest that application of MSFragger to affinity purification 
experiments can provide insights into a wide array of modifications, including rare and low 
abundance ones, on highly enriched proteins. Furthermore, open searching may offer better 
accounting of protein abundances using spectral counts in AP-MS experiments and improve the 
quality of recovered interaction networks derived using interaction scoring tools [112,113]. 
 
Table 4-1 
List of genes associated with 'small molecule metabolic process' that have a large increase in identified bait peptide ions 
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Finally, we applied MSFragger to a RNA-protein crosslinking study [104]. Computational 
analysis for such studies can be challenging due to the need to determine a priori a list of 
potential crosslinked products. As open search allows for the identification of peptides with 
unknown modifications, no such list is required. Using a 1,000 Da precursor mass window, we 
performed open search on a run comprising of human UV-crosslinked RNA-protein complexes 
and a control non-irradiated run. We observed highly visible mass shifts associated with peptides 
crosslinked to mono, di, and tri-nucleotides in the irradiated sample that were largely absent from 
the control sample (Figure 4-9c). We compared our results to that of the RNPxl computational 
strategy described in the original study and found that open search confidently identified 163 
crosslinked species, compared to 189 reported by RNPxl, with 134 identifications in common. 
As expected, the open search strategy failed to identify some of the crosslinked species 
containing very short peptides due to an insufficient number of unmodified fragment ions 
(Figure 4-9c inset). On the other hand, MSFragger identified 29 additional crosslinked species, 
most of which (all except 4) were from proteins containing other crosslinked peptides already 
identified by RNPxl. Furthermore, MSFragger also identified a number of modified peptides 
from various RNA-binding proteins (including some not identified by RNPxl) with mass shifts 
that approximate the RNA crosslinks.  These peptides are likely crosslinked peptides that also 
contain some other chemical modification or adduct and are thus undetectable by the RNPxl 
strategy. Examples include the peptides YGRPPDSHHSR and SYGRPPPDVEGMTSLK from 
the protein SRSF2 (which was not identified by RNPxl despite identifying 5 other proteins from 
the SRSF family).  This shows that MSFragger provides a simple but highly effective analysis 
workflow for identification of protein-RNA crosslinked peptides, and demonstrates the added 
insights gained through open searching in any experimental setup.  
4.4 Discussion 
The refinements to the open search strategy were met with varying success. We demonstrated 
that peptides with the most common modifications could be recovered by combining variable 
modifications with open searching, which is important for enabling the use of open searching in 
quantitative proteomics experiments using labeling technologies. Failure to recover unmodified 
peptides using a boosting option suggest that the missing peptides may be of borderline quality 
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and could potentially be false positives that are eliminated by open searching. While the addition 
of complementary ions helped recover a number of modified peptides with modifications near 
the C-terminus, it did not increase the overall number of identified peptides. Directly searching 
for shifted fragment ions in the future should help increase the recovery of such modifications as 
well as the overall number of modified peptides.  
 
The vast array of chemical and biological modifications adds a dimension to proteomics that is 
not fully explored in most studies. Open database searching, made practical using MSFragger 
can, in conjunction with existing workflows, simultaneously and comprehensively identify 
modified and unmodified peptide forms. The diversity of chemical modifications in different 
experiments is revealing in that we cannot simply use a predefined set of common modifications 
but that they vary in abundance or may be unique to particular experimental workflows or labs. 
Monitoring the rates of these common chemical modifications is also important for 
reproducibility in quantitative proteomics experiments, especially when relying on quantification 
of selected peptides as proxies for estimating abundance of their corresponding protein [114]. 
 
Given the fast growth of public repositories of MS data [100], MSFragger could be used to 
search for rare (including novel) biological modifications across many biological samples and 
experimental conditions, adding to the list of previous such discoveries [115]. This includes 
large-scale cancer proteomics studies [116,117] where using the open search strategy can 
potentially identify novel PTMs that are involved in cancer processes. Open searching could be 
advantageous for characterization of neoantigens and other endogenous peptides[71,118], many 
of which are present in modified forms. The comprehensive identification of modified peptides 
using the open search strategy not only reduces the number of false positives in any proteomics 
workflow, but also provides exciting opportunities for the study of post-translational 
modifications. 
4.5 Data availability 
Raw mass spectrometry files are available from public repositories as described. The processed 
data files supporting the findings of this study are available upon request. 
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CHAPTER V 
FUTURE EXPLORATIONS                                                    
BEYOND THE REFERENCE PROTEOME  
5.1 Conclusions 
Mass spectrometry has emerged as the method of choice for high-throughput proteome analysis. 
Advances in instrumentation over the past decade have allowed us to collect data of such depth 
and quality that we can now observe the vast majority of proteins that are inferred by the protein 
coding genes in the genome. However, these advances have been accompanied by growing pains 
as the development of statistical and computational methods has not kept pace with that of 
instrumentation and they struggle with challenging tasks such as the identification of novel 
peptides in proteogenomics, notably in the control of false positive identifications. In this 
dissertation, I presented computational strategies that identified and reduced false positives for 
the purpose of improving the quality and sensitivity of proteogenomics studies. 
 
In Chapter Two of the dissertation, I provided a direct strategy for studying false positives by 
using high scoring decoy identifications that are generated from the target-decoy approach. 
Using this strategy and existing tools in an automated fashion, I was able to determine the 
fractions of false positives that were produced due to ambiguous scoring functions, semi-tryptic 
peptides, and modified peptides. While the percentage may vary from dataset to dataset, in the 
triple negative breast cancer dataset examined, these three categories represent nearly 80% of all 
false positives. As we were able to automatically annotate them by using multiple search engines 
or expanded search spaces, this suggests that we could eliminate them by incorporating these 
strategies in regular peptide identification workflows. We also demonstrate that false positives 
due to modified peptides may be underestimated using the target-decoy strategy by violating the 
assumption that incorrect assignments match at equal rates to target and decoy sequences. Using 
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both experimental and theoretically generated spectra, we demonstrate that there is a greater 
propensity for modified peptides to map to target sequences, likely due to spectra homology 
between the spectra of modified peptides and those of other unmodified target peptides. 
 
Database searches using multiple search engines, semi-tryptic searches, and open searches (to 
identify modified peptides) all serve to provide additional information that can be used to reduce 
the number of false positives. However, the computational costs of performing all such searches 
are impractical. In Chapter Three, we presented two database search tools that are much more 
efficient than current database search tools, enabling comprehensive analyses on large datasets. 
The first tool, EGADS, uses GPUs to accelerate both in-silico digestion and similarity scoring 
and provided speedups of 30-40X over conventional tools in common search scenarios. The 
three different scoring kernels implemented in EGADS might allow it to serve as multiple search 
engines and resolve ambiguous identifications. The second tool, MSFragger, uses a fragment 
indexing algorithm to simultaneously score experimental spectrum against a range of theoretical 
spectra without the use of specialized hardware. For open searches, MSFragger is over 150X 
faster than existing tools making them feasible for identifying blind modifications in large 
datasets. Together, these tools eliminate the bottlenecks that might be cause by database 
searching, allowing for more comprehensive peptide identification and reduction of false 
positives. 
 
In Chapter 4, we refined the open search strategy for identifying modified peptides and applied it 
to a large number of shotgun experiments as well as other proteomics applications. Refinements 
of the open search strategy demonstrated the compatibility of the strategy with variable 
modification searching allowing common modifications to be fully recovered and enabling open 
search to be applied to labeling based quantitative proteomics experiments. We also increased 
recovery of peptides with modifications near the C-terminus and discussed other nuances of the 
open search strategy. We profiled a number of shotgun experiments and discovered that rates of 
chemical and biological modifications are quite dissimilar between experiments with some 
possessing unique modifications. We also discovered a number of labile modifications that 
showed no evidence for the modification in their tandem mass spectra. Finally, we applied the 
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open search strategy and identified modified peptides in a number of proteomics applications 
demonstrating their pervasiveness and the added information they provide. 
5.2 Future Directions 
The automated pipeline used to identify sources of high scoring decoys can be adapted to use the 
highly efficient database search tools developed to examine sources of false positives across 
other large datasets. The sampling depth of the experiment (from faster instruments or extensive 
fractionation) might increase the number of modified peptides sampled, leading to become a 
larger source of false positives. Low-resolution tandem mass spectra may also lower 
identification confidences for ambiguous identifications due to a more robust null distribution 
used in score calibration.  
 
The integration of multiple search engines, search spaces, and modified peptides can be 
challenging. While the pipeline used to explain high scoring decoys proceeded in a multi-stage 
approach, applying a similar approach can result in the trapping of false positives at an early 
stage (i.e. multiple search engines agree on the same false positive identification when there is a 
much better semi-tryptic or modified peptide explanation). A statistical framework is needed to 
establish the prior distributions of each input score, including the abundance estimation of 
modifications, in order to calibrate the scores and select the best explanation for a particular 
spectrum. The integration of different search spaces have been examined to some extent [56] 
using existing tools [69] but it is unclear whether those tools can be effectively used to integrate 
these wildly different search spaces. 
 
The apparent violation of the target-decoy assumption by modified peptides requires a much 
deeper examination in both regular shotgun experiments and proteogenomics studies. Further 
experiments are needed to eliminate the effect of chimeric spectra in the work based on observed 
experimental data. A simple strategy might involve re-searching experimental spectra with 
modified peptides that have the fragment ions of the identified peptide removed and rejecting 
them from downstream analysis if a high quality match is found (indicating a chimeric spectra). 
The extent of this violation can also be determined for different modifications in order to 
investigate whether they occur only for modifications that have masses corresponding to single 
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amino acid substitutions. These estimations can then be used to infer the degree of FDR 
underestimation in current proteomics studies at the PSM, peptide, and protein levels. 
 
While the goal of these tools is to improve the quality of proteogenomics studies, they can also 
be applied to existing repositories and datasets to identify false positives that have been included 
in the current observed proteome (proteins that have been “confirmed” by mass spectrometry but 
are actually false positives). A strategy might involve the re-analysis of all spectra present in 
repositories such as GPMDB and flag any suspicious spectrum. Proteins that are only supported 
by suspicious spectra can then be manually inspected and possibly removed from the list of 
identified proteins. Performing similar validation tasks for proteogenomics studies can be 
complicated by their heterogeneity and use of custom databases. 
 
EGADS is limited in the design of its memory manager and cannot operate on large protein 
databases that might be found in meta-proteomics studies. Changing the way the protein database 
is loaded onto GPU memory is a possibility but a simpler approach may be to simply partition 
the database into smaller segments and store partial search results for each spectrum and 
combine the search results after the final segment has been processed (similar to how MSFragger 
partitions the search space when there is insufficient memory to hold the entire fragment ion 
index). The application to meta-proteomics could be quite interesting due to EGADS’s ability to 
rapidly process large sequence search spaces. 
 
EGADS can also be used as a first pass tool for the automated detection and annotation of raw 
data that is submitted to a repository of mass spectrometry data. A non-specific search of all 
proteins can quickly identify the organism and enzymatic cleavage patterns as well as instrument 
mass accuracy and calibration. This set of information can be used to correct the data and 
determine search parameters in subsequent processing of the dataset, all without manual 
intervention and annotation – which can be error prone. 
 
The algorithm behind MSFragger can be used to power a new class of peptide identification 
tools that can enable analysis not currently feasible due to the computational costs. This includes 
the direct searching of spliced peptides or fusion peptides by searching protein subsequences 
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(using the shifted fragment index described below) without regards for the precursor mass and 
merging the results afterwards to “stitch” the two subsequences into a complete peptide. Other 
applications might involve large-scale spectra clustering (at a repository level) to identify spectra 
that have very different fragmentation patterns that might be indicative of a false positive. 
 
More immediately, the use of a shifted fragment index (indexing ions based on the difference 
between their mass and their precursor masses) will allow the searching of mass shifted 
fragments and improve the ability to identify modified peptides using the open search strategy. 
Care must be taken to not double count experimental fragments for both the y-ion and y+ Δ-ion 
series. Concurrent searching of both indices would prevent this double counting but can be 
technically challenging to implement. The use of this modified algorithm for identifying 
modified peptides should be compared to the conventional open search strategy to establish 
differences in identification rates and to determine if there are novel C-terminal modifications 
that can be identified using this strategy that cannot be identified using the conventional open 
search strategy. 
 
The use of the fragment ion-indexing algorithm can also be used to power direct searches against 
collections of spectra at a repository scale in real time, enabling researchers to establish mass 
spectrometry evidence for a particular peptide or modification interactively. A prototype of this 
application has demonstrated that millions of spectra can be effectively searched in tens of 
milliseconds but the scalability to hundreds of millions or billions of spectra remains to be tested. 
Alternative explanations from a variety of searches (enzymatic, semi-tryptic, open) will need to 
be pre-computed for each spectrum in the database to establish whether the newly tested 
hypothesis is better than the others that have been already tested. Statistical frameworks will 
need to be established to encompass the multiple search spaces from very heterogeneous 
experiments (different instruments, mass accuracies, digestions etc.). 
 
The ability to identify large numbers of modified peptides in large-scale proteomics experiments 
is exciting as it opens up many avenues of inquiry from both a methods development and 
biological perspective. The varying rates of chemical modifications could have consequences for 
quantitative proteomics. Investigating ways on how to select peptides that are unlikely to be 
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modified or incorporating the abundances of modified peptides in abundance estimation could 
improve such experiments by reducing variance and thus increase statistical power. Technical 
replicates of the same sample (and the same or different labs) could serve as benchmarking 
datasets. 
 
The study of biological modifications from open search results could be a boon for the 
proteomics field as a whole as they cannot be assayed by inexpensive sequencing technologies. 
Even for well-characterized PTMs that have established enrichment protocols, the large number 
of non-enriched experiments covering a wide range of tissues could add tissue specific 
knowledge of these PTMs. Rare (and novel) PTMs can also be studied using open searching but 
precautions must be taken to avoid errors from incorrect charge state assignment or co-
fragmentation. These modifications can be compiled into a resource for community curation and 
follow up by biochemical studies. 
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Appendix A 
EXAMPLES OF HIGH SCORING DECOYS 
 
 
 
Figure A-1 Example of high scoring decoy due to ambiguous scoring. 
(Top) Decoy peptide identified with high confidence. (Bottom) Forward peptide identified with high confidence. The matched 
fragments are identical in mass indicating that both matches are of equal quality in the absence of a predicted fragmentation 
model.  
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Figure A-2 Example of high scoring decoy due to semi-tryptic peptide. 
(Top) Decoy peptide identified with high confidence. (Bottom) Forward semi-tryptic peptide identified with high confidence.  
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Figure A-3 Example of high scoring decoy due to unaccounted for modification. 
(Top) Decoy peptide identified with high confidence. (Bottom) Forward peptide identified with oxidation on tryptophan.  
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Appendix B 
SUPPLEMENTARY MATERIALS FOR  
EFFICIENT DATABASE SEARCH TOOLS 
 
Table B-1 Analysis times for a single file (b1906_293T_proteinID_01A_QE3_122212) in HEK293 dataset using different 
search engines.  
All benchmarking was performed on a E3-1230v2 (4 cores with hyperthreading at 3.3 GHz) workstation unless otherwise noted 
using 8 threads. Breakdowns of indexing and search time provided where applicable.  Times do not sum to overall search time 
due to input/output and other overhead. 
 
*performed on a 2xE5-2609v2 (2 processor, each with 4 cores at 2.5GHz) workstation, peptide indexing timed only for open 
search (PD uses cached index) 
#Tide is unable to accommodate precursor tolerance windows larger than 100Da 
**MSFragger was restricted to a single thread in comparisons against tools (MODa, Tide) that do not make use of multiple 
threads of execution 
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Table B-2 EGADS runtime across diverse search conditions. 
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Appendix C 
SUPPLEMENTARY MATERIALS FOR  
COMPREHENSIVE PROFILING OF MODIFIED PEPTIDES 
 
 
Figure C-1 Localization profiles are consistent across experiments.  
Common modifications were selected and amino acid localization enrichment was calculated separately for each dataset.  Amino 
acid localizations were largely consistent across each dataset despite the differences in modification rates. 
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Figure C-2 Highly similar spectra pair for peptide LEAEIATYR with precursor mass difference of 284.126.  
3214 PSMs (corresponding to 1087 unique peptides) were identified in the mass difference bin of 284.126 Da.  These PSMs were 
predominantly observed in the HeLa dataset and were shown to have a spectral similarity score of 0.90 (indicating that the 
spectra of mass shifted peptides are highly similar to that of corresponding unmodified peptides).  Here, we selected a pair of 
PSMs that were both identified to be the peptide LEAEIATYR in the same LC-MS/MS run. Despite their highly similar 
fragmentation patterns and few unmatched fragments, they were observed with precursor masses that differ by 284.1251 Da.  The 
full y-ion series was successfully matched, which when overlapped with the matched b-2, b-3, and b-4 ions, rules out the 
possibility of a modified residue in the fragmentation spectrum. 
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Table C-1 Mass shift localization by dataset. 
BinStart Lower bound of mass shift in bin 
BinEnd Upper bound of mass shift in bin 
LocPSMs Number of PSMs in which the mass shift could be localized 
TotalPSMs Total number of PSMs within this bin 
Nterm Rate at which mass shift is localized on N-terminal end of peptide (percentage) 
TopAA1 1st highest enriched amino acid with enrichment ratio 
TopAA2 2nd highest enriched amino acid with enrichment ratio 
TopAA3 3rd highest enriched amino acid with enrichment ratio 
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Table C-2 List of top 500 detected features in mass shift histogram with potential explanations. 
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Appendix D 
MSFRAGGER MANUAL  
 
Introduction 
 
MSFragger is an ultrafast database search tool for peptide identifications in mass spectrometry-
based proteomics.  It differs from conventional search engines by computing similarity scores in 
a fragment-centric fashion using a theoretical fragment index of candidate peptides.  The speed 
of MSFragger makes it particularly suitable for ‘open’ database searches, where the precursor 
mass tolerance is set to hundreds of Daltons, for the identification of modified peptides.  
MSFragger is implemented in the cross-platform Java programming language and is compatible 
with standard proteomics file formats such as MGF/mzXML/mzML/pepXML. 
 
Equipment 
 
Computer Hardware requirements 
 
The processor requirements of MSFragger depends on the complexity of your search (and your 
patience to wait for search results).  For an open search (500Da precursor mass window) using a 
tryptic digest of the human proteome, a single processor core can search roughly 40,000 MS/MS 
spectra in under an hour.  MSFragger scales well with the number of processor cores and 
runtimes of under 2 minutes per file have been achieved using a 28-core workstation.  A desktop 
workstation with a quad core processor is sufficient for most simple workflows. 
 
MSFragger requires substantial amounts of memory due to its in-memory fragment index.  While 
MSFragger can operate with less memory than needed to store the fragment index, it will cause 
index fragmentation where it breaks the search into multiple passes, searching each input file 
against a small segment of the index at a time (which greatly increases the runtime).  For the 
human Uniprot protein database with reversed decoys, approximately 3700 MB of memory is 
needed to prevent index fragmentation.  The actual size of the fragment index is substantially 
lower (MSFragger uses a very 
conservative estimate of the available free memory to avoid out of memory 
situations).  Specifying common modifications may boost memory requirements to  
6 GB.  Semi-tryptic, non-enzymatic, and phospho searches may take tens of gigabytes 
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to avoid fragmented searches.  Limiting the range of peptide lengths can reduce the search space 
and reduce memory consumption in such cases. While fragment index fragmentation is 
undesirable, it may be unavoidable in certain instances.   
 
We recommend at least 8GB of memory for workflows involving standard tryptic digestions. 
 
Operating System requirements 
 
MSFragger has been tested on Mac OS X, Windows 7, and a number of Linux distributions.  
Note that a 64-bit operating system is required to access more than 4GB of memory. 
 
Java requirements 
 
MSFragger is written using Java 1.8 and requires the Java 8 Runtime Environment.  We 
recommend the Oracle Java 8 Runtime (download and installation instructions are available at 
www.java.com). 
 
Procedure 
 
Preparing Input Files 
 
Mass spectrometry data must first be converted to one of the supported MS/MS input formats of 
MGF, mzXML, or mzML.  A popular option for converting from vendor file inputs and between 
various input formats is Proteowizard (proteowizard.sourceforge.net).  MSFragger determines 
the appropriate data parser to use based on the file extension (.mgf for MGF, .mzXML for 
mzXML, and .mzML for mzML) and does not make inferences from file contents (i.e. naming a 
mzML file with the .mzXML extension will lead to unpredictable results or crashes). 
 
The protein database must be supplied in FASTA format.  MSFragger does not have the 
capability to generate decoys internally so they must be generated externally and appended to the 
protein database before running MSFragger. 
 
Configuring MSFragger 
 
Extract the MSFragger.jar into your working directory along with the sample configuration file 
called fragger.params.  MSFragger is configured using a text parameters file.  The parameters 
file is passed as the first argument to MSFragger and has no restrictions on names or file 
extensions (so one might want to name their configuration files to be more descriptive such as 
Uniprot_open_withmods.txt) after editing the parameters file for a particular analysis. 
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Parameter names are given left of the equal sign and parameter values are given to the right (e.g. 
num_threads = 4).  White spaces are trimmed from the ends of each value by MSFragger.  All 
text to the right of (and including) the # sign of each line is discarded so # can be used for 
comments in the parameters file. 
 
Table D-1 Listing of MSFragger search parameters. 
 
General Parameters 
 
num_threads Number of CPU threads to use, should be set to the number of logical 
processors; a value of 0  (auto-detect) will cause MSFragger to use the 
auto-detected number of processors 
 
Default: 0 
database_name Path to the protein database file in FASTA format 
 
Search Tolerances 
 
 
precursor_mass_tolerance Precursor mass tolerance (window is +/- this value) 
 
Default: 20 
precursor_mass_units Precursor mass tolerance units (0 for Da, 1 for ppm) 
 
Default: 1 
precursor_true_tolerance True precursor mass tolerance (window is +/- this value).  Used for tie 
breaker of results (in spectrally ambiguous cases) and zero bin boosting 
in open searches (0 disables these features).  This option is STRONGLY 
recommended for open searches. 
 
Default: 0 
precursor_true_units True precursor mass tolerance units (0 for Da, 1 for ppm) 
 
Default: 1 
fragment_mass_tolerance Fragment mass tolerance (window is +/- this value) 
 
Default: 20 
fragment_mass_units Fragment mass tolerance units (0 for Da, 1 for ppm) 
 
Default: 1 
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isotope_error Isotope correction for MS/MS events triggered on isotopic peaks.  
Should be set to 0 (disabled) for open search or 0/1/2 for correction of 
narrow window searches.  Shifts the precursor mass window to multiples 
of this value multiplied by the mass of C13-C12. 
 
Default: 0 
 
In-silico Digestion Parameters 
 
search_enzyme_name Name of enzyme to be written to the pepXML file. 
 
Default: Trypsin 
search_enzyme_cutafter Residues after which the enzyme cuts (specified as a string of amino 
acids) 
 
Default: KR 
search_enzyme_butnotafter Residues that the enzyme will not cut before (misnomer: should really be 
called butnotbefore) 
 
Default: P 
num_enzyme_termini Number of enzyme termini (0, 1, or 2 for non-enzymatic, semi-
enzymatic, fully-enzymatic) 
 
Default: 2 
allowed_missed_cleavage Allowed number of missed cleavages 
 
Default: 2 
digest_min_length Minimum length of peptides to be generated during in-silico digestion 
 
Default: 7 
digest_max_length Maximum length of peptides to be generated during in-silico digestion 
 
Default: 64 
digest_mass_range Mass range of peptides to be generated during in-silico digestion in 
Daltons (specified as a space separated range) 
 
Default: 500.0 5000.0 
 
Variable Modification Parameters 
 
clip_nTerm_M Specifies the trimming of a protein N-terminal methionine as a variable 
modification (0 or 1) 
 
Default: 0 
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variable_mod_01 .. 07 Sets variable modifications. (variable_mod_01 to variable_mod_07).  
Space separated values with 1st value being the modification mass and 
the second being the residues (specified consecutively as a string) it 
modifies. 
 
* is used to represent any amino acid 
[ is a modifier for protein N-terminal 
] is a modifier for protein C-terminal 
n is a modifier for peptide N-terminal 
c is a modifier for peptide C-terminal 
 
Syntax Examples:  
15.9949 M (for oxidation on methionine) 
79.66331 STY (for phosphorylation) 
-17.0265 nQnC (for pyro-Glu or loss of ammonia at peptide N-terminal) 
 
Example (M oxidation and N-terminal acetylation): 
variable_mod_01 = 15.9949 M 
variable_mod_02 = 42.0106 [* 
allow_multiple_variable_mods_on_res
idue 
Allow each amino acid to be modified by multiple variable 
modifications (0 or 1) 
 
Default: 1 
max_variable_mods_per_mod Maximum number of residues that can be occupied by each variable 
modification (maximum of 5). 
 
Default: 2 
max_variable_mods_combinations Maximum allowed number of modified variably modified peptides from 
each peptide sequence, (maximum of 65534).  If a greater number than 
the maximum is generated, only the unmodified peptide is considered. 
 
Default: 5000 
 
Spectrum Processing Parameters 
 
minimum_peaks Minimum number of peaks in experimental spectrum for matching 
 
Default: 10 
use_topN_peaks Pre-process experimental spectrum to only use top N peaks 
 
Default: 50 
minimum_ratio Filters out all peaks in experimental spectrum less intense than this 
multiple of the base peak intensity 
 
Default: 0.0 
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clear_mz_range Removes peaks in this m/z range prior to matching.  Useful for 
iTRAQ/TMT experiments (i.e. 0.0 150.0). 
 
Default: 0.0 0.0  
max_fragment_charge Maximum charge state for theoretical fragments to match (1-4). 
 
Default: 2 
override_charge Ignores precursor charge and uses charge state specified in  
precursor_charge range (0 or 1) 
 
Default: 0 
precursor_charge Assume range of potential precursor charge states.  Only relevant when 
override_charge is set to 1.  Specified as space separated range of 
integers. 
 
Default: 1 4 
 
Open Search Features 
 
track_zero_topN Track top N unmodified peptide results separately from main results 
internally for boosting features.  Should be set to a number greater than 
output_report_topN if zero bin boosting is desired. 
 
Default: 0 
zero_bin_accept_expect Ranks a zero-bin hit above all non-zero-bin hit if it has expectation less 
than this value. 
 
Default: 0.0 
zero_bin_mult_expect Multiplies expect value of PSMs in the zero-bin during results 
ordering (set to less than 1 for boosting). 
 
Default: 1.0 
add_topN_complementary Inserts complementary ions corresponding to the top N most intense 
fragments in each experimental spectra.  Useful for recovery of 
modified peptides near C-terminal in open search.  Should be set to 0 
(disabled) otherwise. 
 
Default: 0 
 
Modeling and Output Parameters 
 
min_fragments_modelling Minimum number of matched peaks in PSM for inclusion in statistical 
modeling 
 
Default: 3 
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min_matched_fragments Minimum number of matched peaks for PSM to be reported.  We 
recommend a minimum of 4 for narrow window searching and 6 for 
open searches. 
 
Default: 4 
output_file_extension File extension of output files 
 
Default: pep.xml 
output_format File format of output files (pepXML or tsv) 
 
Default: pepXML 
output_report_topN Reports top N PSMs per input spectrum 
 
Default: 1 
output_max_expect Suppresses reporting of PSM if top hit has expectation greater than 
this threshold  
 
Default: 50.0 
 
Static Modification Parameters 
 
add_Cterm_peptide Statically add mass in Da to C-terminal of peptide 
 
Default: 0.0 
add_Nterm_peptide Statically add mass in Da to N-terminal of peptide 
 
Default: 0.0 
add_Cterm_protein Statically add mass in Da to C-terminal of protein 
 
Default: 0.0 
add_Nterm_protein Statically add mass in Da to N-terminal of protein 
 
Default: 0.0 
add_C_cysteine 
... 
add_X_usertext 
Statically add mass to cysteine (or whatever amino acid is specified 
after ‘add_’). 
 
Examples: 
add_C_cysteine = 57.021464  
add_K_lysine = 144.1021 
 
Default: 0.0 
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Running MSFragger 
 
Performance Considerations for Batch Processing 
 
MSFragger allows multiple MS/MS input files to be processed in a batch.  Passing multiple files 
to MSFragger at once allows MSFragger to reuse the fragment index for subsequent MS/MS run.  
This is particularly important for narrow window searches which may only take fractions of a 
second. 
 
On computers or compute clusters with many processor cores, we highly recommended that 
MSFragger is set to process files sequentially with all available processor cores rather than 
running multiple instances of MSFragger in parallel (assigning a smaller number of cores to 
each).  This reduces initialization times and allows the fragment index to be re-used, at the same 
time reducing overall memory requirements. 
 
Launching MSFragger 
 
Ensure that you have placed MSFragger.jar in your working directory and have modified the 
parameters file to reference your protein database.  MSFragger generates auxiliary files during 
database search so it is critical that MSFragger must have write access to the directories 
containing the protein database AND the MS/MS data files. 
 
Determine the amount of system memory available that you would like to make available to 
MSFragger.  This will be specified by the Java maximum heap size parameter -Xmx (e.g. -
Xmx3700M for 3700 MB or -Xmx8G for 8GB).   
 
MSFragger takes the first argument as the input parameters file, followed by a list of one or more 
MS/MS data files. 
 
Examples:  
java -Xmx8G -jar MSFragger.jar fragger.params HeLa_run1.mzML HeLa_run2.mzML 
java -Xmx8G -jar MSFragger.jar fragger.params *.mzML 
 
The -Xmx flag is very important to ensure that MSFragger has access to sufficient memory to 
efficiently perform the search as the default max heap setting in Java is ¼ of total system 
memory (which is insufficient for optimal performance).  We recommend that you can allocate a 
minimum of 4G or 6G for standard tryptic digestions. 
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Expected Behavior 
 
The first time running MSFragger on a new protein database or set of search parameters with a 
given database, it will first perform an in-silico digestion, create, and cache the peptide index (in 
.pepindex files adjacent to where the FASTA database is stored).  These pepindex files can be 
safely removed at any time and should be removed to free up disk space when a set of search 
parameters is no longer used (MSFragger will automatically re-generate the index as needed). 
 
The process begins with filtering and in-silico digestion subject to the digestion parameters. 
 
 
Figure D-1 In-silico digestion in MSFragger.  
 
Followed by peptide sorting and de-duplication.  The non-redundant set of peptides are then 
evaluated to generate the set of variably modified peptides (based on the specified variable 
modifications) which are then sorted by mass and stored. 
 
 
Figure D-2 Peptide index generation in MSFragger.  
 
After peptide index generation is complete (or is read from disk in the below screenshot).  
MSFragger selects the fragment index bin width to use and estimates the memory available for 
fragment index storage based on the available memory (in this case, 8GB of memory was made 
available to the Java Virtual Machine, of which MSFragger estimates that 4976.67MB can be 
safely reserved for fragment index operations).  It then computes the number of theoretical 
fragments to be generated for the entire index, the number of slices or iterations (in multi-pass 
searches when there is insufficient memory), and the total amount of memory represented by the 
entire fragment index.  The fragment index is then generated, and a time is reported for the index 
generation time (at the end of each Operating on slice 1 of X: line, 4770 ms below).  If the 
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maximum fragment slice size is very small compared to your desired amount of system memory 
or the number of slices is unexpectedly high, double check that the -Xmx flag is correctly set. 
Search begins and the current file is reported, along with the time needed to read and pre-process 
the MS/MS data, along with current search progress. 
 
Figure D-3 Fragment index searching in MSFragger.  
 
At the completion of the search, a completed time is reported, and the results are written to disk 
in the same folder as the MS/MS data (if they are not in the same folder as your working 
directory).  Note that there is a current bug that causes MSFragger to incorrectly display the 
average rate of matching at the conclusion of the run (although the total time can be divided by 
the total number of spectra to calculate this value). 
 
 
Figure D-4 MSFragger searching in batch mode.  
 
Output Files 
 
Table D-2 Listing of MSFragger output files. 
 
.fragtmp In cases of fragment index fragmentation (in limited memory scenarios), MSFragger will 
iteratively load each MS/MS run and search loaded spectra against the current index slice 
before working on the next index slice.  The partial search results are then stored in these 
.fragtmp files.  In the event that MSFragger is terminated in the middle of a search, it will 
recover its partial results using these files. At the end of the last index slice, MSFragger 
will read all such .fragtmp files and generate an aggregated results file (identical to one 
that would be generated if it had the memory to search against all peptides in a single 
pass).  These .fragtmp files are then automatically deleted.  These can be safely removed if 
you no longer wish to continue an aborted search or if MSFragger somehow fails to 
remove them at the conclusion of a successful search. 
 
Location: Same directory as MS/MS files 
.pepindex  MSFragger stores the computed peptide index in .pepindex files adjacent to the protein 
database files to remove the need to re-compute the index if search parameters are 
unchanged in subsequent runs.  These .pepindex indices can be safely removed and 
MSFragger will re-compute the index again at runtime if needed. 
 
Location: Same directory as protein database 
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Results Files 
(eg. .pep.xml) 
These are the pepXML or TSV output files containing the peptide identifications.  The file 
extension is specified in the search parameters so specifying a .pep.xml extension with 
output_format = tsv will output .pep.xml files with TSV content. 
 
Location: Same directory as MS/MS files 
 
Interpretation of Output 
 
For pepXML outputs, these can be used for downstream processing using PeptideProphet in TPP 
directly.  For viewing of results or conversion to other peptide identification result formats for 
use in other pipelines or tools that do not support pepXML, we recommend first converting to 
the mzIdentML format using the tool idconvert as part of the ProteoWizard package.  The 
pepXML generated by MSFragger validates against v 1.18 of the pepXML schema and should 
be compatible with any downstream tools supporting the pepXML format. 
 
The output fields of the TSV file produced by MSFragger are listed below: 
ScanID 
Precursor neutral mass (Da) 
Retention time (minutes) 
Precursor charge 
Hit rank 
Peptide Sequence 
Upstream Amino Acid 
Downstream Amino Acid 
Protein 
Matched fragment ions 
Total possible number of matched theoretical fragment ions 
Neutral mass of peptide (including any variable modifications) (Da) 
Mass difference 
Number of tryptic termini 
Number of missed cleavages 
Variable modifications detected  
(starts with M, separated by |, formated as position,mass) 
Hyperscore 
Next score 
Intercept of expectation model (expectation in log space) 
Slope of expectation model (expectation in log space)
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